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ABSTRACT 
The increasing prevalence of non-tuberculous infections together 
with the problems associated with conventional detection 
techniques stress the importances of establishing a new, rapid, 
specific and sensitive assay for the detection of non-tuberculous 
Mycobacteria. 
The Polymerase Chain Reaction {PCR} has been demonstrated to 
exhibit extreme sensitivity and specificity for a wide variety of 
infectious agents including M.tuberculosis and M.leprae. A PCR 
assay for non-tuberculous Mycobacteria has not yet been 
established. The aim of this study therefore, was to develop a 
PCR assay for detection of the clinically important non-
tuberculous Mycobacteria. 
I was able to develop a PCR assay, using one set of primers, 
which could detect, M.tuberdulosis, M.bovis ECG, M.avium-
intracellulare and M.kansasii. The assay was extremely sensitive 
(one organism) and also specific for these Mycobacteria. 
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1.1 Introduction 
CHAPTER 1 
LITERATURE REVIEW 
The discovery of the tubercle bacillus by Koch in 1882 was made 
possible by the use of the Acid Fast stain as well as the 
preparation of appropriate culture media and the recognition that 
visible growth may only occur after 4 to 6 weeks of incubation. 
(Koch 1932, English translation). With this new knowledge it 
soon became apparent that there were acid fast bacteria that did 
not cause tuberculosis. These non-tuberculous Mycobacteria were 
considered to be saprophytic. This assumption was based on the 
observation that these organisms were not pathogenic in guinea 
pigs and therefore, when they occurred in human tissue, they were 
labelled contaminants (Brem 1909, Pinner, 1935). It was only in 
the mid 1950s with the development of effective chemotherapy for 
M.tuberculosis and with more widespread culturing of biologic 
fluids with positive acid-fast smears that researchers 
demonstrated that there were persons with tuberculosis-like 
diseases from whom only non-tuberculous Mycobacteria could be 
isolated and that these organisms were the causal agents of the 
disease (Buhler and Pollak 1954, Timpe and Runyon 1954). 
Finally, with the statement by Runyon in 1959 that "the guinea 
pig no longer sits alone on the throne of decision as to 
pathogenicity of acid-fast bacilli for man", most workers 
recognised the human pathogenicity of the non-tuberculous 
Mycobacteria. Since then the recognition of new pathogenic and 
non-pathogenic species · increased rapidly to the point where there 
are now more than 54 species in the genus Mycobacterium. 
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The collective term used to embrace all the Mycobacteria other 
than M.tuberculosis and M.leprae remains controversial (Collins 
et al 1984). The terms "atypical", "anonymous" and "opportunist" 
bacteria are used mainly in the United States and United Kingdom 
while some authors prefer the terms "non-tuberculous" or 
"Mycobacteria other than tubercle (MOTT)". For the purpose of 
this thesis the term "non-tuberculous Mycobacteria" will be used. 
1.2 Classification 
The first workable classification of the non-tuberculous 
Mycobacteria was introduced by Runyon in 1959. This 
classification was developed mainly from the morphological 
features (pigmentation and growth rates) of 120 clinical isolates 
of non-tuberculous Mycobacteria (Table 1.1). The basic concept 
of this classification remained for many years and newly 
identified Mycobacteria were simply added to Runyon's groups 
(Table 1.1) . 
However, it is now preferable to identify mycoacterial organisms 
by species rather than by group since each species may have its 
own cultural, biochemical, genetic and clinical characteristics. 
Because of close similarities, there is, however, some 
controversy that the species standing is appropriate for some of 
the Mycobacteria. M.avium and M.intracellulare are so similar 
that they are difficult to differentiate by routine chemical 
tests. Only DNA relatedness studies (Baess 1979) and DNA probes 
(Drake et al 1987) have demonstrated that these are in 
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Table 1.1: Classification of Non-Tuberculous Mycobacteria 
Group I 
Photochromogens 
(slow-growing) 
Group II 
Scotochromogens 
(slow-growing) 
Runyon 1959 
"yellow bacilli" 
M.kansasii 
"orange bacilli" 
Group III 
Non-photochromogens 
(slow-growing) 
"Battey type" 
Group IV 
Rapid growers M.fortuitum 
Norcardia 
Good 1979 
M.kansasii 
M.marinum 
M.simiae 
M.scrofulaceum 
M.szulgai, M.xenopi 
M.gordonae 
M.flavescens 
M.avium-intracellulare 
M.ulcerans, M.malmoense 
M.fortuitum 
M.chelonei 
M.smegmatis 
M.phlei 
fact different organisms. It has, therefore, been suggested 
(Good 1985) that species that resemble each other biochemically 
and pathogenically be considered as complexes eg. M.avium complex 
(MAC) includes M.avium and M.intracellulare. 
1.3 Epidemiology 
Most species of pathogenic non-tuberculous Mycobacteria have been 
cultured from various sources in the environment. They have been 
isolated from soil, dust, sewage material, water and raw milk 
(Goslee and Wolinsky 1976, Kubica et al 1961, O'Brien et al 1987, 
Dunn and Hodgson 1982). Furthermore, it has been well 
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demonstrated in the United States that geographic variation in 
prevalence rates occurs and these occurrence patterns have 
remained relatively unchanged {Good 1985). The incidence of 
M.avium for example is greatest in the southeastern part of the 
United states and is associated with coastal plains and surface 
waters. This geographic distribution of M.avium-M.intracellulare 
had previously also been demonstrated by the skin test reaction 
rates {PPD prepared from M.avium complex) of us Navy recruits 
from different states (Edwards et al 1969). M.kansasii on the 
other hand is found mainly in the central states and high 
incidence areas form an inverted T extending to include Florida 
on the- east and California on the west {Good and Snider 1982). 
The exact mechanism of transmission of non-tuberculous 
Mycobacteria is not known but person to person spread appears 
unlikely. However, the saprophytic existence and the presence of 
geographic variation suggest~that transmission is from non-human 
sources probably in the form of aerosols from estuary water. 
Gruft and colleagues (1975) demonstrated that in the southeast, 
prevailing winds can create potentially infectious aerosals from 
stagnant estuary waters, thus giving rise to human exposure, 
colonisation and.possibly disease. Furthermore, it has recently 
been established that there is a correlation between the 
increased presence of plasmids in clinical and aerosol isolates 
of M.avium-M.intracellulare as compared to isolates from water, 
soil and dust (Meisner and Falkinham 1986). 
' 
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The incidence of non-tuberculous mycobacterial infection in 
developed countries has increased markedly over the years. In 
1957 only 1-2% of mycobacterial isolates were non-tuberculous 
(Crow et al 1957). In 1980, the Centre for Disease Control 
analysed 32 ooo isolates and showed that 66% were M.tuberculosis 
(Good 1980, Good and Snider 1982). In the period 1983 to 1987, 
Saboulle examined 366 clinical isolates and showed that only 21% 
were M.tuberculosis. Of the non-tuberculous Mycobacteria M.avium 
complex was most frequently isolated (61%) followed by M.kansasii 
(15%) (Saboulle 1989). 
The relative increase and importance of infections due non-
tuberculous Mycobacteria is due partly to the progressive decline 
in the incidence of M.tuberculosis. However, evidence suggests 
that the actual prevalence of these infections has increased 
(O'Brien et al 1987). 
It has been emphasised in several large studies (Rosenzweig 1979, 
Yeager and Raleigh 1973, Hornick et al 1988) that most patients 
with M.avium complex infection have underlying chronic lung 
disease and that infection without pedisposing factors is 
uncommon. Furthermore, non-tuberculous Mycobacteria have 
recently been associated in increasing numbers with the acquired 
immune-deficiency syndrome (AIDS) (Kiehn et al 1985a, Levy-
Frebault et al 1987, Horsburgh and Selik 1989). The increased 
incidence of· non-tuberculous Mycobacteria, may therefore, reflect 
increasing age and prevalence of chronic lung disease as well as 
increasing numbers of immune compromised patients. 
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More recently, however, it has been demonstrated that a 
substantial and rising number of infected patients have no 
evidence of predisposing conditions (Prince et al 1989). This 
suggests that there are other unknown factors which may 
contribute to the increasing incidence of non-tuberculous 
mycobacterial infections. One explanation may be increasing 
virulence of the organism, a fact which appears to be 
substantiated by recent studies showing plasmid associated 
enhancement of virulence among certain strains of M.avium complex 
recovered from patients with AIDS (Gangadharam et al 1988). 
1.4 Clinical syndromes 
Because of the high environmental prevalence and the low 
virulence of non-tuberculous Mycobacteria, interpretation of 
positive cultures is often difficult. In order to distinguish 
clinical disease from colonisation or contamination certain 
~ 
criteria have been suggested (Ahn et al 1982, American Thoracic 
Soc 1981, Wolinsky 1981). These include: presence of clinical 
and roetgenographic evidence compatible with the disease process; 
repeated isolation of the same organism from multiple specimens 
acquired at different times; quantity of growth on primary 
culture; site of specimen; host risk factors and the failure to 
identify other disease etiologies. 
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The spectrum of disease due to these organisms is very wide. 
Non-tuberculous Mycobacteria are most often recovered from 
pulmonary specimens (81%}, followed by lymph modes (7%), skin and 
soft tissue (2%}, gastric aspirates (<1%), as well as other 
fluids and tissues (O'Brien et al 1987). Systemic dissemination 
of non-tuberculous Mycobacteria was not usually encountered 
before the AIDS epidemic, but is now often seen in AIDS patients, 
who frequently have M.avium positive blood cultures. The primary 
manifestations, predisposing factors, and species involved in 
non-tuberculous mycobacterial disease are summarised in 
Table 1.2. 
Resistance to traditional antituberculous agents is common in 
non-tuberculous Mycobacteria and the use of up to six 
antimicrobial agents in combination is common but not always 
effective. 
1.s 
1.s.1 
Laboratory Diagnosis 
Laboratory Culture 
Isolation and identification of species in the genus 
Mycobacterium still relies almost entirely on laboratory culture. 
Media used for culture of M.tuberculosis (eg. Lowenstein-Jensen) 
are used by most laboratories for isolation and identification of 
non-tuberculous Mycobacteria. 
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Also, as for M.tuberculosis, various decontaminating procedures 
are used prior to culture to kill organisms other than the 
Mycobacteria. The rationale for these procedures is that the 
high lipid content of the mycobacterial cell wall is more 
resistant to alkali and acids and therefore eliminates common 
bacterial flora while not compromising the viability of the 
Mycobacteria. 
Laboratory culture of Mycobacteria can detect less than 10 
organisms per inoculum (Hobby et al 1973) and identification of 
the organism by a variety of biochemical tests makes 
identification possible. However, generation rates for slow 
growers vary from 15 to 24 hours (David 1973, Gutierrez-Vasquez 
1956) with visible growth occurring only after 12 to 42 days of 
incubation. The slow growth rate is the major drawback of 
V 
conventional culture methods' as therapeutic decisions often need 
to be made within the 24 hr admission period. 
A further disadvantage of culture methods is that viable 
organisms are necessary and a bacteriological diagnosis may be 
missed should the decontamination procedure be too harsh or if 
the patient has received treatment prior to specimen collection. 
Once colonies of the Mycobacteria have become visible, a · further 
3 to 4 weeks incubation is usually required to produce a lawn of 
mycobacterial growth which is sufficient for all the biochemical 
tests necessary for species identification. The specific tests 
10 
and schemes used to identify mycobacterial isolates vary between 
laboratories. The ·scheme used at Groote Schuur Hospital is shown 
in Table 1.3. Most schemes of identification first exclude 
M.tuberculosis by the niacin test. Niacin is formed as a 
metabolic by-product by all Mycobacteria and most species possess 
an enzyme that converts free niacin to niacin ribonucleotide. 
M.tuberculosis, however, lacks this enzyme and niacin 
accummulates and can be detected by a colorimetric test based on 
the reaction between niacin and cyanogen bromide (Runyon et al 
1959, Konno 1956). Further identification begins with 
observations . of pigmentation, rate of growth, and incubation 
temperature, the results of which may direct selection of further 
tests. 
Most Mycobacteria can be distinguished by these biochemical 
tests. However, no single biochemical test reliably 
distinguishes M.avium from_M.intracellulare (Meissner et al 
1974). M.avium but not M.intracellulare can, however, grow well 
at 43° and M.intracellulare cannot cause progressive disease in 
birds. 
1.s.2 Microscopy 
The Mycobacteria have a unique staining characteristic ie. 
binding the stain carbol fuchsin so tightly that it resists 
destaining with strong decolourizing agents such as alcohol and 
strong acids. This acid fastness has in the past been attributed 
to a number of cell wall components but it now appears that the 
most likely explanation is that complexes are formed between the 
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12 
dye and the mycolic acid residues which then traps the dye and 
renders the organism acid-fast. 
Two procedures are commonly used for acid fast staining ie carbol 
fuchsin methods which include Ziehl-Neelsen and Kinyon-staining 
procedures, and fluorochrome methods using either auramine o or 
auramine-rhodamine dyes. 
Carbolfuchsin methods are simple, require only a light microscope 
but must be scanned with an oil immersion objective, which 
greatly restricts the area of the slide that can be viewed in a 
given period of time. Flurochrome stained slides, however, 
because of the high contrast between background and organism can 
easily be scanned at low magnification, but has the disadvantage 
that fluorescent microscopes are required. Some authors consider 
that fluorescent methods give rise to false positive results due 
to the presence of naturallyy occurring fluorescent particles 
(Ritterhoff and Bowman 1945, Collins et al 1981), others have 
however disputed this (Kubica 1980). The sensitivity of 
carbolfuchsin and flurochrome methods is similar (Kubica 1980). 
It has been demonstrated that detection of Mycobacter~a by 
microscopy requires the presence of 5000 to 10000 bacilli per ml 
of sputum (Yeager et al 1967, Hobby et al 1973) and staining 
procedures are therefore, rather insensitive. However, in those 
patients with active disease there is good correlation with 
culture and microscopy, and microscopy therefore provides a good 
first line detection system for active disease. 
13 
staining is in most cases non-specific and cannot be used to 
differentiate the species of Mycobacteria. A few species do, 
however, exhibit characteristic acid fast morphology which may 
assist in directing biochemical testing eg. M.kansasii are 
elongated and exhibit a barred or beaded appearance (Nassau and 
Hamilton 1957). M.avium complex are usually coccoid or 
coccobacillary (Grange 1984). 
1.5.3 Radiometric Culture 
In 1969 Deland and Wagner developed a technique for the detection 
of microbial growth and metabolism by measuring the conversion of 
substrate labelled with carbon-14 to (14c) o2 with an ion chamber 
device. Modification of this technique is now used routinely for 
detection of microbial growth in blood cultures. Radiometric 
detection of Mycobacteria was first described in 1975 (Cummings 
et al 1975) and its usefulness in clinical specimens described in 
1977 (Middlebrook et al 197r.). 
The procedure is relatively simple: an aliquot of the specimen is 
inoculated into a bottle containing Middlebrook 7H12 medium 
supplemented with 14c-labelled palmitic acid (Bactec 12A). An 
antibiotic mixture of polymixin B, amphotericin B, naladixic 
acid, trimethoprim and azlocillin is reconstituted with 
polyethylene stearate (a growth promoting substance for many 
Mycobacteria) and added to the bottle. Thereafter, (14cJ o2 is 
measured daily and the culture is examined microscopically and 
subcultured if a significant growth index is demonstrated. 
14 
The clinical usefulness of the radiometric method was assessed in 
several trials, using a wide variety of specimen types including 
sputum, urine, tissue, CSF and gastric washings. The findings of 
some of these trials are summarised in Table 1.4. It would 
appear that the detection efficiency (sensitivity) of the 
radiometric method is comparable with that of conventional 
culture methods. However, the advantage of this method lies in 
the much faster recovery times {2-3x), which has obvious clinical 
and therapeutic implications. 
Although radiometric culture methods can rapidly detect 
mycobacterial growth, further identification by conventional 
testing may require up to six weeks for completion. A major 
advance therefore, was made when it was demonstrated that the 
radiometric technique can also be adapted to differentiate the 
M.tuberculosis complex from other Mycobacteria by use of the NAP 
test {Siddiqi et al 1984). ~AP (pNitro-a-acetylamino-b-
hydroxypropiophenone) is an inhibitor of members of the 
M.tuberculosis complex but not of other Mycobacteria. The test 
requires on average, an additional 5 days once growth has been 
documented radiometrically. 
A number of studies {Snider et al 1981, Vincke et al 1982) 
compared drug susceptibility from cultures obtained by 
radiometric and conventional methods and found that there was 
good correlation. The use of the radiometric method for combined 
primary recovery and drug susceptibility testing was, however, 
first demonstrated by Roberts and colleagues (1983). After a 
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16 
positive growth index is demonstrated the test drug can be added 
and the change in growth index measured. Using this procedure, 
Roberts demonstrated an overall agreement of 95-100% between the 
two methods. The average. additional time for drug susceptibility 
results ranged from 4,2 to 6,9 days for the combined method and 
13,7 to 21 days for the conventional methods. 
Culture positive mycobacteraemia due to M.tuberculosis was 
reported in the 1930s (Jensen 1935, Shapiro 1932) and the 
radiometric detection of mycobacteraemia was first shown when 
Landau (Landau et al 1980) isolated, from two immunosuppressed 
patients, Mycobacterium chelonei subsp abscesses using standard 
aerobic BACTEC bottles (6B). Because of the intracellular 
location of pathogenic Mycobacteria, the lysis of peripheral 
white cells before inoculation into appropriate media needed to 
be . considered. A lysis centrifugation blood culture technique 
had previously been described for the detection and isolation of 
bacteria and fungi from blood (Dorn and Smith 1978). With this 
method blood is inoculated into a double-stoppered, evacuated 
tube (Isolator: E.I du Pont de Nemoun and Co., Inc.) containing 
sodium polyethanol sulfonate, EDTA and the lysing agent, Saponin. 
After centrifugation the supernatant fluid is discarded and the 
pellet plus residual fluid is inoculated into the appropriate 
media. M.chelonei was the first mycobacterium detected by this 
procedure (Fojtasek and Kelly 1982) followed by the detection of 
M.tuberculosis bacteraemia in 1985 (Kiehn et al 1985). Since 
then a number of authors have demonstrated that mycobacteraemia 
due to M.tuberculosis or other Mycobacteria can be detected by 
17 
using this lysis procedure combined with radiometric techniques 
(Gill et al 1985, Kiehn and Cammarata 1986). 
In order to circumvent the need for a separate isolator, Johnson 
Laboratories introduced 13A medium. This medium was compared 
with the isolator system and shown to have the same sensitivity 
and slightly faster detection times (Witebsky et al 1988). A 
major advantage of this system is that less manipulation is 
required, resulting in less exposure to possible HIV positive 
samples from patients with associated mycobacteraemia. 
In order to improve the sensitivity and speed of the radiometric 
system, analysis of the incubated bottles by ELISA (Friedman et 
al 1989) and by nucleic acid probes (Ellner et al 1988) has been 
reported. Ellner and colleagues, using a commercially available 
DNA probe (Gen. Probe), documented a reduction in the time of 
detection and also the elimination of the need for biochemical 
tests on isolates giving a positive reaction with one of the 
probes. Friedman and colleagues (1989), using a commercially 
available anti-BCG antibody documented the detection of 
M.tuberculosis antigen within 10 days. 
1.5.4 Chromatographic Procedures 
The chemical detection and differentiation of My~obacteria has 
been an attractive possibility since the demonstration by 
Anderson of the uniqueness and complexity of mycobacterial cell 
wall lipids (Anderson 1943). 
18 
Various chromatographic techniques have been employed in an 
attempt to separate the lipids or other cell components and so to 
define characteristic profiles which could be used to 
differentiate and detect the various Mycobacteria. 
As early as 1954 column chromatography and detection by infared 
spectroscopy was used to characterise mycobacterial species and 
to distinguish bovine from human strains (Smith et al 1954). 
Later, in several studies thin layer chromatographic analysis of 
lipids was used to differentiate many types of non-tuberculous 
Mycobacteria (Jenkins et al 1972, Szulga et al 1966). This 
procedure was further adapted by differentiating mycobacterial 
species incubated with c35 sJ methionine by the patterns of 
radioactive lipid spots (Tsukamura and Mizuno 1975). 
It was, however, not until the introduction of gas liquid 
chromatography (GLC} that good discrimination between the 
different Mycobacteria could be achieved. The gradual 
improvements seen in GLC of the Mycobacteria are related to 
improvements in the extraction and derivitisation of specimens as 
well as the development of more sensitive detection systems. 
Pyrolysis GLC of whole cells was successfully employed in a 
series of studies by Reiner and colleagues to classify and 
identify many mycobacterial strains (Reiner 1965, Reiner 1967, 
Reiner et al 1969a, Reiner et al 1969b, Reiner et al 1971). 
19 . 
It was, however, felt that better discrimination would be 
achieved by initial extraction of lipid followed by GLC. This 
was first achieved by Lucchesi who showed that Mycobacteria could 
be differentiated by GLC of methylated lipid extracts {Lucchesi 
et al 1967). Later work by Thoen and colleagues demonstrated 
good differentiation of Mycobacteria by characteristic branched 
chain fatty acids {Thoen et al 1971a, Thoen et al 1971b, Thoen et 
al 1972). 
The lipid extraction procedures were complex and a single step 
extraction of whole cell hydrolysates was at the time seen as a 
major advance (Ohashi et al 1977). With this procedure they were 
able to distinguish mycobacterial species rapidly and also 
demonstrate a unique chromatographic peak for M.tuberculosis. 
Tisdall and colleagues {Tisdall et al 1979) developed an 
identification scheme using 1pecific chromatographic patterns 
from 128 stock strains. In a later study of 335 routine 
mycobacterial isolates they showed good correlation of the 
chromatographic patterns with conventional biochemical profiles 
{Tisdall et al 1982). A further study of 110 isolates using a 
modification of the previous methods also showed good correlation 
with biochemical tests {Mayai 1985). 
As mycolic acids make up a large proportion of the lipid content 
of the cell wall, various attempts have been made to analyse the 
cleavage products of mycolic acids (Kaneda et al 1986, Guerrant 
et al 1981, Valero-Guillen et al 1985, Lambert et al 1986). 
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Although these results appear promising the instability of myolic 
acids at high temperatures and their high boiling points may make 
these compounds unsuitable for routine GLC analysis. 
Although GLC procedures can be used to identify and differentiate 
many of the non-tuberculous Mycobacteria, a number of 
disadvantages need to be considered. Most GLC methods require 
well grown cultures of Mycobacteria and this may take a further 
2-3 weeks after detection of the organism. GLC also requires 
considerable expertise and equipment is expensive. 
Chromatographic procedures have not been used to reliably 
differentiate the most common pathogens ie. M.avium and 
M.intracellulare. Perhaps the greatest disadvantage of GLC is 
that the direct detection of non-tuberculous Mycobacteria in 
clinical specimens has not yet been achieved. This is not 
surprising as there are numerous variables which would 
undoubtedly influence the Gtc patterns ie. the complexity of the 
body fluids and factors which control or influence its 
composition; the variables introduced by specimen collection; 
transport; extraction and derivitisation; and finally the 
analysis and interpretation of complex data generated by such 
investigations. One would therefore, require the presence of a 
compound unique to the organism or combinations of compounds 
which give distinct patterns to those of the control fluids and 
this would require~ large number of clinical specimens both 
normal and mycobacterial in order to establish these differences. 
Furthermore, in order to detect the small amount of compound in a 
body fluid more sophisticated detector systems would have to be 
21 
used. These problems have largely been overcome for 
M.tuberculosis where GLC and mass spectrometry have been used to 
detect the compound tuberculostearic acid (French et al 1987a, 
French et al 1987b). No compound specific for any of the non-
tuberculous Mycobacteria has yet been described. 
1.s.s Nucleic Acid Detection 
one of the first applications of nucleic acid technology in 
mycobacterial detection and differeDtiation was the study of 
genome size, guanine-cytosine (GC) composition and relationships 
between Mycobacteria based on deoxyribonucleic acid 
reassociation. 
All the Mycobacteria were shown to have genome sizes of between 
3-5 x 109 daltons with the closely related M.tuberculosis, 
M.bovis and M.bovis BCG having smaller genomes than the other 
Mycobacteria (Baess and Mansa 1978). 
All the Mycobacteria have high GC contents of between 66-70% and 
belong to the high GC subdivision of gram positive bacteria, 
which includes the Actinomycetes such as streptomyces and 
Nocardia. studies of GC content confirmed that Corynebacteria 
and Mycobacteria should be separate genera and that the Nocardia 
and Mycobacteria are more closely related (Hill 1966). Further 
studies based on GC content indicated a bimodal clustering in 
terms of GC content among the different Mycobacteria, but the 
separation did not correspond to the division of the species into 
slow and rapid growers (Wayne and Gross 1968). 
22 
It soon became apparent that one could determine relatedness 
amongst Mycobacteria by the degree of DNA reassociation. By 
using DNA from one or two Mycobacterial species as standards 
numerous researchers published relatedness based on percentage 
homology with the "standard" DNA. Bradley (1973) showed marked 
overlap of Nocardia with Mycobacteria while numerous other 
authors indicated variable degrees of relatedness among the 
various Mycobacteria (Baess 1982, Gross and Wayne 1970, Baess and 
Bentzon 1978, Bradley 1972, Imaeda 1982). 
Another approach for differentiation of Mycobacteria was to 
establish species or strain specific banding patterns of 
restriction digests of genomic DNA. Patel and colleagues (1986} 
were able to demonstrate specific banding patterns in nine 
mycobacterial species and were also able to differentiate 
M.tuberculosis strains based on the banding patterns. Collins 
and De Lisle {1987) were abl e to differentiate BCG by specific 
restriction fragment patterns. Shoemaker and colleagues (1986) 
differentiated 15 species of M.tuberculosis by restriction enzyme 
patterns of MboI digests of genomic DNA. 
Profiles of the plasmids found in the M.avium - M.intracellulare 
- M.scrofulaceum {MAIS) complex have been used as epidemiological 
markers and from these results the authors concluded that MAIS in 
natural aerosols may contribute significantly to human 
colonisation and disease (Meissner and Falkinham 1986). Crawford 
and Bates (1986) isolated plasmids from 26 strains of M.avium 
23 
complex and suggested that plasmids may be associated with . 
virulence. The association of virulence with plasmids in M.avium 
was also demonstrated by Gangadharam and colleagues (1988)-. 
Furthermore, an association between the presence of plasmids and 
antibiotic resistance in M.avium complex has also been 
demonstrated (Franzblau et al 1986}. 
Because of the uniqueness of the DNA from a particular organism, 
various researchers set about to identify specific DNA probes 
which would hopefully also be more sensitive than other 
established methods of diagnosis. Roberts and colleagues (1987} 
used whole chromosomal probes for both M.tuberculosis and M.avium 
and were able to detect as few as 104 organisms and correctly 
identified the species in 93% of mycobacterial cultures grown on 
agar plates. 
w 
A commercially available, r 125 labelled, single stranded, DNA 
probe complementary to the ribosomal DNA of the M.tuberculosis 
complex, M.avium anQ M.intracellulare respectively, has become 
available {Gen-Probe Corp., San Diego, California}. These probes 
have been primarily used for the identification of Mycobacteria 
once isolation has been accomplished. This identification may be 
particularly useful in the case of the M.avium complex where 
M.avium and M.intracellulare are difficult to differentiate by 
conventional means. The results of 3 studies {Table 1.5) 
indicate high sensitivity and specificity and identification can 
be achieved within 2 hrs. 
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A number of investigators have developed specific probes for the 
detection of M.tuberculosis {Pao et al 1988, Patel et al 1989, 
Eisenach et al 1988). However, the sensitivity of these probes 
is similar to that of the Ziehl Neelsen stain and therefore the 
use of DNA probes for direct detection of Mycobacteria in 
clinical specimens is not practicable. This is in contrast to 
the detection of mycobacterial DNA in clinical specimens by the 
polymerase chain reaction (de Wit et al 1990, Brisson-Noel et al 
1990, Shankar et al 1990, Eisenach et al 1990, Patel et al 1990, 
Woods and Cole 1989) which appears to be highly sensitive and 
specific. This procedure and relevant studies will be discussed 
in the following section. 
1.6 
. 1.6.1 
Polymerase Chain Reaction 
Introduction 
The polymerase chain reaction {PCR) is an in vitro method for the 
enzymatic synthesis and ampl~fication of specific DNA sequences. 
The concept of PCR was first introduced as early as 1971 (Kleppe 
et al 1971). This early reference has, however, only recently 
received attention, but the last paragraph of this paper clearly 
describes a mechanism almost identical to PCR:-
"The principles for extensive synthesis of the duplexed tRNA 
genes which emerge from the present work are the following. The 
DNA duplex would be denatured to form single strands. This 
denaturation step would be carried out in the presence of a 
sufficiently large excess of the two appropriate primers. Upon 
cooling, one would hope to obtain two structures, each containing 
the full length of the template strand appropriately complexed 
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with the primer. DNA polymerase will be added to complete the 
process of repair replication. Two molecules of the original 
duplex should result. The whole cycle could be repeated, there 
being added every time a fresh dose of the enzyme. It is 
however, possible that upon cooling after denaturation of the DNA 
duplex, renaturation to form the original duplex would 
predominate over the template primer complex formation. If this 
tendency could not be circumvented by adjusting the 
concentrations of the primers, clearly one would have to resort 
to the separation of the strands and then carry out repair 
replication. After every cycle of repair replication, the 
process of strand separation would have to be repeated. 
Experiments based on these lines of thought are in progress". 
It was 14 years later, however, that the PCR methodology was 
introduced (Mullis et al 1986, Mullis Faloona 1987) and it was 
initially used to amplify siecific B globin genomic sequences for 
the diagnosis of sickle cell anaemia (Saiki et al 1985). 
The principle of PCR is illustrated and described in Fig 1.1 
Because products synthesised in one cycle serve as a template in 
the next, the increase in specific fragment is exponential. The 
theoretical amplification can therefore be expressed as 2n, where 
n is the number of cycles performed. In practice, however, the 
extent of amplification is (l+x)n where xis the average 
efficiency of each cycle. Amplifications of 10
5 and 106 are 
usually achieved in a JO-cycle procedure. 
POLYMERASE CHAIN REACTION 
Denature 
l Anneal Primers 
• • 
Extension 
• • 
~ole/12 l 
• • 
Fig. 1.1: Double stranded DNA with target sequence ( f~~~~-­
is shown at top of diagram. Separation of the strands 
(Denaturation) is achieved by heating the strands to 95°c. 
Primers (Iii) are then annealed to complementary sequences of the 
target sequence by lowering the temperature to 55°c. Extension 
of the primers occurs via a DNA polymerase and is achieved by 
raising the temperature to 10°c. Denaturation, primer annealing 
and extension represent one cycle. At the end of cycle I the 
newly synthesised strands are longer than the target sequence but 
by the end of cycle 2 correct target sequence length is being 
synthesised. Thirty such cycles are usually performed in a 
standard PCR assay. 
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The ability to amplify specific DNA sequences by such an order of 
magnitude represents a major advance in molecular biology and 
this is reflected in the large number of applications of PCR 
since its introduction 5 years ago. 
1.6.2 components and Parameters 
Although PCR appears to be a relatively simple procedure it is in 
fact a complex and incompletely understood biochemical brew and 
because of the large number of components, parameters and 
biochemical interactions, it is convenient to examine each 
separately and attempt to assess how it may affect the total 
reaction. 
1.6.2.1 DNA Polymerase 
The initial PCR studies were performed with DNA polymerase I, 
Klenow fragment (Mullis and Faloona 1987, Saiki et al 1985). 
Because the enzyme lacked stability at denaturing temperatures of 
95°C fresh emzyme was added at the beginning of each extension 
step. As the temperature optimum for this step was 37°C 
extension at this low temperature allowed for significant non-
specific binding of oligonucleotide primers (Saiki et al 1988) 
and hence non-specific synthesis of amplification products. 
These disadvantages were soon overcome when the thermostable DNA 
polymerase from Thermus aquaticus (Taq polymerase) was introduced 
(Saiki et al 1988). 
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strains of Thermus aquaticus were first isolated from thermal 
springs in Yellowstone Park (Brock and Freeze 1969) and are now 
known to be inhabitants of acquatic thermal environments both 
natural and man-made. The organism is a gram negative, non-
sporulating, non-motile rod; successful enrichment requires 
incubation at 70-75°C. 
DNA polymerase was purified from T.aquaticus (Chien et al 1976) 
and was shown to have a temperature optimum of 80°C and to be 
stable at 93°C to 95°C. The pH optimum was 8,0 and the molecular 
weight as determined by sucrose density gradient centrifugation 
and gel filtration was 63 000 to 68 000. The specific activity 
of the purified Taq polymerase was 2 000 to 8 ooo units/mg. More 
recent purifications of Taq polymerase (Gelfand 1989) yield an 
enzyme with specific activity of 2000 000 unit/mg and a molecular 
weight on SOS polyacrylamide gels of about 95 ooo. A molecular 
weight of 93 910 has been inferred, based on DNA sequence 
information (Lawyer et al 1989). 
The effect of temperature on the activity of Taq polymerase is 
shown in Fig 1.2. The skewed curve shows significant activity at 
lower temperature, optimum activity at 8o0 c and hardly any 
activity above 90°C. 
The activity expressed as processivity rate (ie. number of 
nucleotides incorporated per sec) is also optimum at 75-ao 0 c (150 
nt/sec) as shown in Table 1.6. 
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FIG 1.2: TEMPERATURE PROFILE OF TAQ POLYMERASE 
1111 
The effect of temperature on the activity of Tag polymerase. The 
incorporation of [ 3HJdTTP into DNA was measured at different 
temperatures (From Chien et al 1976). 
r 
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TABLE 1.6: EFFECT OF TEMPERATURE ON PROCESSIVITY RATE 
RATE TEMPERATURE REFERENCE 
150nt/sec 75°c - 80°C Gelfand 1989 
60nt/sec 70°c Innes et al 1988 
24nt/sec 55°c II 
1,5nt/sec 37°c II 
0,25nt/sec 22°c II 
The effect temperature has on the stability of the enzyme has 
been investigated (Gelfand 1989). He showed that after 
incubation for 130 minutes at 92°c there was still 50% residual 
activity. In addition, there was 50% residual activity after 
incubation at 95°c for 40 minutes or 97°c for 6 minutes. 
Therefore, if 30 cycles are performed with a denaturatio~ step of 
one minute at 95°C per cycle there should still be sufficient 
activity remaining at the end of the reaction. At higher 
temperature, however, the ef-ficiency of the reaction would be 
reduced. 
Early workers (Chien et al 1976) demonstrated the absolute 
requirement of Taq polymerase for the divalent cation Mg2+. The 
concentrations of this cation and its relationship with dNTP will 
be discussed later. The effect of KCl, gelatin, salt solutions 
and Dimethyl sulphoxide (DMSO) on Taq polymerase will be 
discussed later. 
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Tag DNA polymerase does not contain 3'-5'exonuclease, 
proofreading activity (Chien et al 1976, Tindall & Kunkel 1988) 
and this taken together with the decrease in stability of the DNA 
duplex at higher temperatures one would expect a significant 
increase in incorrectly incorporated nucleotides. Tag polymerase 
produces single-base substitution errors at a rate of 1 for each 
9000 nucleotides and frameshift errors at a frequency of 1 per 
41000 nucleotides (Tindall and Kunkel 1988). In comparison, the 
Klenow fragment shows a misincorporation frequency which is 6 to 
8-fold less than Tag polymerase (Tindall and Kunkel 1988). There 
is only a twofold increase in misincorporation rate of Tag 
polymerase for reactions performed at 7o 0 c versus ss 0 c. It is 
not entirely clear how non-proofreading Tag polymerase can 
maintain such high fidelity. Experimental evidence indicates 
that Tag polymerase extends a mismatched primer template 
significantly less efficiently than a matched primer template and 
y 
this may be related to a binding cleft on the polymerase which 
"fits" matched pairs better than mismatched pairs (Petruska et al 
1988) . 
Whether a proofreading exonuclease exists in vivo but has been 
dissociated from the Tag polymerase during purification remains 
to be determined. 
Tag DNA polymerase has some DNA synthesis dependent, strand 
replacement, 5'-3' exonuclease activity (Gelfand, 1989). This 
does not appear to have any effect on PCR reactions. Tag 
polymerase shows considerable amino acid sequence homology with 
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E.coli Polymerase I (Lawyer et al 1989). Significant similarity 
is shown in the domains containing the 5'-3' exonuclease 
activity. This data may explain the observed exonuclease 
functions. 
More recently the Taq polymerase gene has been cloned and 
expressed in E.coli (Lawyer et al 1989} and the cloned gene 
product is commercially available (Ampli Taq. Cetus Corporation}. 
DNA polymerases from a number of other thermophilic organisms 
have also been purified and partially characterised. (Kaboev et 
al 1981, Ruttiman et al 1985, Klinezak et al 1986}. Possibly 
some of these polymerases will have advantages over Taq 
polymerase, but this still has to be demonstrated. 
1.6.2.2 Oligonucleotide Primers. 
The primers are probably the most important reaction component in 
determining the success or failure of an amplification reaction. 
The selection, concentration, and the quality of primers can be 
considered seperately. 
The selection of efficient and specific primers remains somewhat 
empirical and only the following guidelines have been offered by 
various authors (Saiki 1989, Saiki et al 1988}: Primers should 
have a random base distribution and the G-C content should be 
similar to that of the target fragment: Stretches of polypurines, 
polypyrimidines and unusual sequences should be avoided: Avoid 
sequences with significant secondary structure, particularly at 
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the 3' end of the primer (certain computer programmes are 
available to predict these structures): Avoid primer 
complementarity. 
With reference to the last point listed above, primers with a two 
to three base overlap at the 3' end will anneal to each other and 
can produce a primer-dimer effect (Saiki 1989). This artefact is 
seen in particular when many cycles of amplification are 
performed on a sample containing very few initial copies of 
template. The primer dimer is a double stranded fragment which 
is close in size to the sum of the two primers. It appears to 
occur when one primer is extended by the polymerase over the 
other primer but the exact mechanism by which this occurs is not 
completely understood. 
The length of primers is an important consideration, as short 
primers can give rise to non-specific amplification. Primers of 
between 20 and 30 bases will give adequate specificity and larger 
primers are not considered necessary. 
If primer concentration is. too high one may expect problems of 
increased non-specific binding and also primer dimer effect. The 
concentration must also not be too low so that primer exhaustion 
occurs: 0,2uM to luM of primer is usually used per reaction. 
Primer quality does not appear to be of great importance. 
Primers can be used directly from the synthesizer but the norm is 
to deprotect for six hours and then ethanol precipitate directly 
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from ammonium hydroxide. Further purification is not considered 
necessary. 
1.6.2.3 PCR Buffer 
components and component concentrations vary between authors and 
manufacturers and are largely determined by the particular 
characteristics and requirements of the primer/template 
combination. The various components that have been incorporated 
in PCR buffers will be considered in the following paragraphs. 
The magnesium concentration in particular appears to have a 
marked effect on PCR efficiency and specificity. Generally, 
excess Mg2+ will result in accumulation of non-specific 
amplification products and insufficient Mg2+ will reduce the 
yield of amplification product. The DNA polymerase is sensitive 
to the concentration of magnesium ion ie. 2,0mM MgCl is optimal 
for Taq polymerase activity; whereas higher concentrations are 
inhibitory with 40% to 50% inhibition at lOmM MgC1 2 (Lawyer et 
al 1989). It is the free magnesium ion concentration that is 
important for Taq polymerase activity. Since magnesium ions bind 
in a 1:1 molar ratio with dNTPS, any change in the dNTP 
concentration can markedly effect the free magnesium 
( 
concentration. The Mg requirement will also vary between 
different primer/template/nucleotide/enzyme combinations and, 
therefore, the optimal Mg2+ concentration should be determined 
for each combination. 
36 
Modest concentrati6ns of KCl can enhance the rate of DNA 
synthesis by Tag polymerase by 50% to 60% with an apparent 
optimum at SOmM KCl. Innes and colleagues (1988) suggest that 
KCl can be ommitted. At a concentration of 75mM KCl the activity 
of Taq polymerase can be significantly inhibited. 
Gelatin is usually added as an enzyme stabiliser but evidence 
indicates that this component may also be ommitted in certain 
reactions (Innes et al 1988). 
Deoxynucleotide triphosphates (dNTP) are usually present at 
concentrations of 50 to 200mM each. At these concentrations, 
dNTPs are certainly not limiting and there is sufficient to 
synthesise 6,5mg to 25mg of DNA. Higher concentrations may 
promote base misincorporations by the polymerase (Petruska et al 
1988). The relationship bet,ween free Mg2+ and the dNTP 
concentration has been discussed and both components should 
always be adjusted simultaneously. 
Ten percent DMSO was added to early buffer systems but most 
authors now omit DMSO and some have shown that DMSO can be 
slightly inhibitory to Tag polymerase and decrease the overall 
yield of amplification product (Table 1.7). 
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TABLE 1.7: EFFECT OF DMSO CONCENTRATION ON TAQ POLYMERASE 
ACTIVITY 
DMSO CONCENTRATION 
< 1% 
10% 
20% 
From Gelfand 1989. 
TAQ POLYMERASE ACTIVITY 
100% 
53% 
11% 
Several investigators have observed that the inclusion of 10% 
DMSO facilitates certain PCR reactions, but it is not clear which 
parameters are affected. The DMSO may reduce secondary structure 
of the DNA template, it may affect the melting temperature {Tm) 
of the primers, alter the thermal activity profile of Taq DNA 
polymerase or the degree of product strand seperation achieved at 
a particular denaturation temperature. 
Various salt solutions have different effects on the Taq 
polymerase activity. For example, 50mM ammonium chloride has a 
mild inhibitory effect on Taq polymerase while 50mM ammonium 
acetate has no effect and 50mM sodium chloride has a mild 
stimulatory effect on enzyme activity. 
p-mercaptothanol was used in early buffers but does not appear to 
have any beneficial effect and is not longer used. · 
Besides the components mentioned above other chemicals have been 
used experimentally in an attempt to enhance the efficiency of 
the reaction. The effect of these components on Taq polymerase 
activity is summarised in Table 1.8. 
TABLE 1.8: EFFECT OF CERTAIN COMPONENTS ON TAQ POLYMERASE 
COMPONENT CONCENTRATION ACTIVITY 
ETHANOL <3% 100% 
10% 110% 
UREA <0,5M 100% 
1,0M 118% 
1,5M 107% 
2,0M 82% 
DIMETHY FORMAMIDE <5% 100% 
10% 82% 
20% 17% 
FORMAMIDE <10% 100% 
15% 86% 
20% 39% 
sos 0,001% 105% 
0, OJ.% 10% 
0,1% <0,1% 
From Gelfand 1989 
1.6.2.4 cycling Parameters 
As indicated in Figure 1.1 PCR is usually performed by incubating 
the reaction mixtures at 3 temperatures. 
The denaturing temperature is usually 9o 0c to 95°C. This step is 
critical and it is important that the reaction reaches a 
temperature at which complete strand seperation occurs. on the 
other hand high temperatures and prolonged denaturation time will 
decrease the Taq polymerase activity. 
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The upper limit of the annealing temperature depends on the Tm of 
the primers. The Tm is related primarily to the length and GC 
content of the primers and can be calculated with the use of well 
known equations (Sambrook et al 1989). At temperatures much 
lower than the Tm non-specific binding and therefore non-specific 
amplification will occur. The annealing temperatures must 
therefore be selected within the constraints of these two 
variables. 
Although GC content plays a major role in determining optimum 
annealing temperature there are also probably other minor 
factors. This is illustrated in Table 1.9 where the relationship 
of GC content and optimum annealing temperature are not exactly 
linear. 
TABLE 1.9: EFFECT OF GC CONTENT ON OPTIMUM ANNEALING 
~ TEMPERATURE 
NO OF PRIMERS GC CONTENT OPTIMUM 
PAIRS TESTED ANNEALING TEMP 
9 <60% 60° 
1 60% 60° 
1 62,5% 60° 
1 60% 65° 
1 67,5% 65° 
2 65% 70° 
1 67,5% 70° 
From Kim and Smithies 1988. 
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If short primers (12-15 bases) or primers with mismatched bases 
(degenerate primers) are used then the annealing temperature can 
be much lower e.g. 40°C. Because of the larger molar excess of 
primers present in a reaction mix, hybridisation occurs almost 
instantaneously and long annealing times are not required. 
Extension temperatures should be as close as possible to the 
temperature optimum for Taq polymerase. Although Taq polymerase 
has significant activity at lower temperatures, extension 
temperatures around 70°C are necessary if maximal efficiency is 
required. 
The extension time is dependent on the length of the target being 
amplified. At 70°C the extension rate has been calculated to be 
greater than 60 nucleotides/sec (Innes et al 1988). One minute 
is, therefore, certainly sufficient for target sequences up to 
3kb. An extension time of hmin is also convenient and shorter 
times would not theoretically appear to have any effect on the 
reaction. 
Certain variations in the standard 3 temperature cycle can be 
used under certain conditions, ie. 
- When the Tm of the primers is high, the annealing and extension 
step can be performed at the same temperature (deWit et al 
1990, Kim and Smithie 1988). This simplifies the procedure and 
may further improve specificity. 
) 
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- The extension step can also be eliminated if the target is 150 
bases or less. Due to the significant polymerase activity at 
lower temperatures complete extension can occur during 
transition from annealing to denaturation. 
The time taken for change from one temperature to another (ramp 
time), does not appear to be important other than shortening the 
cycle time. However, if short or degenerate primers are used one 
can anneal at temperatures of 40°C and then gradually heat to 
70°, thus allowing sufficient synthesis in the transition period 
before the possible denaturing conditions for the extension 
temperature are reached. 
It is important to note that it is the sample temperature which 
is critical and not that of the heating block or water bath. The 
sample temperature is routinely measured in most of the newer 
commercially available thermal cycling machines. If this 
facility is not available the test sample temperature should be 
determined during a test amplification. 
1.6.3 Applications of the Polymerase Chain Reaction 
PCR has allowed scientists to synthesise large amounts of 
specific DNA from complex mixtures of templates. This has had a 
tremendous impact on both research methodology and the study of 
disease processes. 
. "--
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1.6.3.1 Research Applications 
Numerous routine procedures such as restriction enzyme analysis 
and preparation of DNA probe, require laborious techniques 
(cloning etc) to produce sufficient material for analysis. This 
problem is now circumvented by PCR. 
Besides the obvious advantages of having more DNA available there 
are several specific research applications which have been 
developed. These are summarised in Table 1.10. 
1.6.3.2 Medical Applications 
PCR methodology has had a tremendous impact in the diagnosis and 
elucidation of pathogenetic mechanisms of human disease. 
PCR has greatly facilitated the diagnosis of many genetic 
disorders. Various PCR modifications have been used for the 
detection of point mutations; small and large deletions; 
identification of possible carriers in x-linked disease and for 
prenatal testing (for review Eisenstein 1990). 
The extensive allelic diversity of the HLA class II loci has been 
ellucidated largely due to PCR (Erlich and Bugawan 1989). This 
has major implications for organ transplantation; for studying 
genetic susceptibility to disease (eg. diabetes mellitus); for 
accurate individual identification for forensic analysis; and for 
detailed evolutionary and phylogenetic studies. 
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PCR has been used to detect residual disease in those conditions 
where there is a specific chromosomal disorder eg. chronic 
myeloid leukaemia and low grade follicular lymphoma (Macintyre 
1989) • 
The study of the relationship of oncogene mutations in certain 
malignant disorders has also been facilitated by PCR (Bos 1989). 
Detection of Y chromosome specific sequences in pre-implantation 
embroys (Handyside et al 1989) and in maternal peripheral blood 
(Lo et al 1989b) by PCR may be invaluable to couples at risk of 
transmitting X-linked disease. 
It is in the field of infectious diseases, however, that PCR has 
had a major impact. The ability to detect single copies of the 
DNA of a particular pathoge~and the fact that the amplification 
is targeted to a particular DNA sequence make PCR a highly 
sensitive and specific diagnostic tool. PCR has also proved 
highly useful in studying the pathogenesis of certain infectious 
diseases as well as in establishing links between certain disease 
processes and possible infective causes. The contribution made 
by PCR for the diagnosis and study of infectious diseases is 
summarised in Table 1.11. As can be seen from the Table 1.11, 
PCR has been applied to a wide range of viruses and to a few 
bacteria and parasites and has proven to be a highly sensitive 
and specific molecular tool. 
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TABLE 1.111 USE OF PCR IN INFECTIOUS DISEASE 
------
1'1i ere-organism · Contribution of PCR 
Reference 
------------
------------
------------
------------
------------
------------
------------
----------
HIV I 
HIV 
HIV 
and II 
HTLV I and II 
HTLV I 
HTLV II 
CMV 
CMV 
CMV 
Hepatitis Viruses 
Detection of viral nucleic acid sequences 
in peripheral blood and tissue culture 
Detection of HIV in paraffin embedded tissue 
Detection prior to generation of antibodies 
ie. seronegative window or those seronegative 
but at risk. 
Screening of neonates from seropositive 
mothers. 
Confirmation that HIV I proviral sequences 
are present mainly in CD4 cells. 
Determining virus type present CHIV I or II> 
Analysis of gene function and regulation 
Identification of HTLV 1 DNA in patients who 
have Adult T-cell Leukaemia. 
Confirming infection in seropositive and 
seronegative individuals. 
Typing the virus present ie. type I or type II 
Documenting HTLVI infection presenting in 
those presenting with symptoms dissimilar to 
classic Adult T-cell lymphoma. 
Documenting prescence of HTLV 1 DNA sequences 
in patients with chronic progressive myelopathy 
and tropical spastic paraparesis. 
Documentation of high prevalence of HTLV 2 
amongst IV drug abusers. 
Detection of CMV ONA sequences 
in tissue culture, peripheral blood and 
urine. 
Diagnosis of congenital CMV infection. 
Detection of CMV in paraffin embedded 
tissue. 
Detection of Hepatitls B DNA i~ serum of 
seropositive patients. 
Detection of Hepatitis B DNA in hepato-
cellular carcinoma. 
Detection of Hepatitis B DNA in paraffin 
embedded tissue. 
Detection of Hepatitis B DNA in normal 
and chronic liver disease patients with 
HB core antibodies only. 
Demonstration of mother-to-infant transmission 
of hepatitis B virus by detection of DNA 
in colustrum. 
Detection of Hepatit~B in normal and 
chronic Hepatitis s ·patients with no 
serological markers for Hepatitis B. 
Ou etal 1988 
Kwok et al 1987 
Hart et al 1989 
Shibata et al 1989 
Loche and Mach 1988 
Edwards et al 1989 
Imagawa et al 1989 
Pezzella et al 1989 
Rogers et al 1989 
Laure et al 1988 
De Rossi et al 1988 
Hufert et al 1989 
Rayfield et al 1988 
Arrigo et al 1989. 
Kwok et al 1988 
Kinoshita et al 1989 
Kwok et al 1988 
Kwok et al 1988 
Kwok et al 1989 
Erhlich et al 1989 
Duggan et al 1988 
Bhavagati et al 1988 
Bangham et al 1988 
Kwok et al 1989 
Lee et al 1989 
Hsia et al 1989 , 
Jiwa et al 1989 
Cassel et al 1989 
Olive et al 1989 
Oemmler et al 1988 
Chehab et al 1989 
Kaneko et al 1989a 
Kaneko et al 1989b 
Ulrich et al 1989 
Lo et al 1989 
Lo et al 1989 
Sumazaki et al 1989 
Mitsuda et al 1989 
Thied et al 1988 
Hepat i tis C 
Human Papilloma 
Virus 
Parvovirus 
819 
Herpes Simplex 
Virus (HSV) 
BK and JC Virus 
Epstein Bar Virus 
Rhinovirus 
Human B-lymphotropic 
Virus 
<H8LV or HHV-6) 
Enterotoxigenic 
E,Coli 
Clostridium 
difficle 
legionella pneu-
mophilia 
Detection of Hepatitis C in some post 
transfusional non-A, non-8 Hepatitis patients, 
HPV DNA virus has been detected in: cervical 
Ca and metastasis in both fresh and paraffin 
embedded tissue. 
in cervical smears of patients with normal 
cytology; 
in dysplasia of cervix 
ie. CIN I - CIN III; 
in normal cervical tissue; 
in other anogenital Ca 
eg. anal, vulvar, penile, vaginal; 
in normal mucosa, benign tumours and 
malignant tumours of the oral cavity; 
in urine of males with meatal 
condylomata accuminata1 
Premalignant and malignant lesions of the 
conjunctiva. 
PCR has also been used to differentiate 
HPV types as an epidemiological tool or 
assessment of those with more oncogenic 
potential, 
Development of a PCR assay which is more 
sensitive than hybridisation techniques, 
Detection of 819 DNA in the tissues of a 
case of intra-uterine death. 
Detection of HSV DNA in paraffin embedded puch 
biopsies of skin lesions. 
Demonstration of HSV gene expression <mRNA) 
during experimental latent infection. 
Detection of viral DNA in urine: from known 
positive immunosuppressed patients, 
from healthy negative patients, 
from negative bone marrow recipients, 
from brain tissue of a patient with 
multifocal leukoencephalopathy. 
Detection of E8V DNA in salivary gland biopsies 
and peripheral blood lymphocytes from patients 
with Sjogren's syndrome. 
Detection of Rhinovirus DNA in nasal washings 
of infected patients. 
Detection of H8LV DNA in a high proportion 
of lympho proliferative disorders and 
peripheral blood of AIDS patients. 
Development of a sensitive PCR assay which is 
specific for bacteria producing a heat 
labile toxin. Detection of the DNA in all 
stool specimens positive by, and one negative 
by bioassay. 
Detection of Clostridium difficle DNA in 
stools by PCR. 
Development of a specific and sensitive PCR 
assay. DNA detecte~fter seeding water with 
L I pne1,1mophi 1 i a. 
Weiner et al 199111. 
Claas et al 1989 
Dallas et al 1989 
Young et al 1989 
Melchers et al 1989 
Cornelsissen et al 
Shibata et al 1988 
Shibata et al 1988 
Kiyabu et al 1989 
Maitland et al 1989 
Melchers et al 1989 
McDonnell et al 1989 
Most of above 
references specify type. 
Salimens et al 1989(a) 
Salimens et al 1989Cb) 
Cao et al 1989 
Lynas et al 1989(a) 
Lynas et al 1989(b) 
Arthur et al 1989 
Saito et al 1989 
Gamma et al 1989 
Buchbinder et al 1988 
Olive 1989 
Wren et al 199111 
Starnbach Set al 
Chlamydia 
Trypanosoma cruzi 
Typanosoma brucei 
and Trypanosoma 
congolense. 
Toxoplasma gondii 
Mycobacteria 
Development of a sensitive PCR assay specific 
to a Chlamydia trachomatis serovars. 
Production by PCR of an oligonucleotide probe 
which may have a level of detection greater 
than culture. 
Specific and sensitive amplification of a 
repetitive element from T.cruzi DNA. 
No detection of DNA sequences in blood 
samples from 2 patients known to be infected 
with T-cruzi. 
Specific and sensitive amplification of 
repetitive elements from DNA of T.brucei 
and T.congolense. Detection of DNA from 
animals infected with these parasites. 
Specific and sensitive amplification of a 
35-fold repetitive sequence of T-gondii DNA. 
Discussed in text. 
Dutilh et al 1989 
Dean et al 1989 
Moser et al 1989Ca> 
Moser et al 1989Cb) 
Burg et al 1989 
·. I 
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Recently, there have been reports of the use of PCR for the 
detection of M.leprae and M.tuberculosis. Woods and Cole {1989) 
described a PCR assay for the detection of M.leprae DNA in 
armadillo liver, mouse footpads and in human biopsy material. 
They amplified two target sequences: a 714 bp fragment encoding 
part of the 65Kd antigen, and a 372 bp fragment which is part of 
an M.leprae specific repetitive sequence. Although cross-
reactivity with other Mycobacteria was not assessed, the assay 
was able to detect the amount of DNA equivalent to that found in 
102 cells. 
Hance and colleagues (1989) amplified a 383 bp fragment encoding 
part of the 65Kd mycobacterial antigen from M.tuberculosis, 
M.bovis, M.avium, M.paratuberculosis and M.fortuitum. After 
amplification, using three oligonucleotide probes they were able 
to distinguish M.tuberculosis and/or M.bovis, M.avium and/or 
M.paratuberculosis and M.fortuitum. the procedure was extremely 
sensitive and the equivalent of 3-60 Mycobacteria could be 
detected. In a subsequent study (Brisson-Noel et al 1989) they 
used this assay to detect M.tuberculosis in a variety of clinical 
specimens (sputum, gastric aspirates, lymph node biopsies and an 
abscess aspirate). 
,.-._ 
Shankar and colleagues (1990) amplified a 240 bp fragment 
encoding part of the MPB 64 protein. The assay was specific for 
members of the M.tuberculosis complex but could not distinguish 
members of this complex. The investigators were also able to 
detect M.tuberculosis DNA ip a variety of clinical specimens 
(sputum, urine and CSF). 
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Eisenach and colleagues (1990) amplified a 123 bp fragment which 
is repeated at least 12 times in the chromosome of 
M.tuberculosis. The assay was specific for, but also could not 
distinguish between members of the _M.tuberculosis complex. 
Sensitivity was excellent (1 organism) but detection of 
M.tuberculosis DNA in clinical specimens was not assessed. 
Patel and colleagues (1990) described a PCR assay for 
M.tuberculosis in which low annealing temperatures were used 
(37°c and 55°c). Amplification of DNA from M.tuberculosis, 
M.bovis, M.bovis BCG, M.kansasii, M.aviu~ and M.intracellulare 
yielded amplification products of varying sizes. One of these 
fragments was specific for M.tuberculosis and was used as a probe 
to distinguish M.tuberculosis from other Mycobacteria. 
Sensitivity was excellent (1 organism) but again detection of 
M.tuberculosis DNA in clinical specimens was not assessed. 
We have recently described a PCR assay (deWit et al 1990) in 
which a 336 bp fragment, which is repeated 10 times in the 
chromosome of M.tuberculosis, is amplified. The assay is 
entirely specific for M.tuberculosis if stringent annealing 
temperatures (7o 0 c) are used. Amplification of DNA from M.bovis · 
BCG yields a 256bp fragment and the assay can therefore 
~ 
distinguish members of the M.tuberculosis complex. The procedure 
is extremely sensitive (10 organisms) and has been used to detect 
DNA in a variety of clinically important specimens (CSF, pleural 
fluids and biopsies and pericardial fluids). 
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1.7 conclusion and Aims of study 
The prevalence of non-tuberculous mycobacterial infections has 
increased markedly over the last decade. However the diagnosis 
and identification of these organisms still relies almost 
entirely on Ziehl Neelsen staining and conventional culture with 
subsequent biochemical testing. These procedures are either 
insensitive or time consuming and attempts have therefore been 
made to develop more rapid diagnostic techniques. None of the 
techniques described fulfill the requirements for a sensitive, 
specific and rapid test. Conventional DNA probes for 
M.tuberculosis although specific and rapid are equivalent to 
Ziehl Neelsen staining in terms of sensitivity and their 
usefulness for the detection of Mycobacteria in clinical 
specimens is therefore not established. 
The PCR assay has been demonstrated to exhibit extreme 
sensitivity and specificity for a wide variety of infectious 
agents including M.tuberculosis. A PCR assay for non-
tuberculosis Mycobacteria has not been extensively investigated. 
The aim of this study was therefore to develop a PCR assay for 
detection of the clinically important non-tuberculous 
Mycobacteria. The approach chosen was to use one set of primers 
and amplify target DNA using low annealing temperatures (4o0 c and 
\ 
so0 c) • 
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It was anticipated that amplification products of varying sizes 
would be generated from the different mycobacterial templates. 
The rationale for this approach came from an observation in a 
previous study (de Wit et al 1990) that amplification of 
M.tuberculosis DNA resulted in non-specific amplification if low 
annealing temperatures were used. The data which form the basis 
of these observations are shown in Fig. 1.3 A similar 
observation was subsequently also made by Patel and colleagues 
(1990) who used low annealing temperatures (37° and ss 0 c) in 
their PCR assay for M.tuberculosis and noted a number of PCR 
products from DNA from non-tuberculous Mycobacteria. 
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Fig. 1.3: Effect of Annealing Temperature on Amplification of 
M.tuberculosis DNA 
3% Agarose Gel. Lane 1, KpnI/SmaI digest of p36 (see Chapter 2) 
Lane 2, Lane 3, Lane 4, Lane 5 and Lane 7. lng of M.tuberculosis 
DNA amplified with an annealing temperature of 35°c, 45°c, ss 0 c, 
7o 0 c and 75°c respectively. Lane 6 20pg of M.tuberculosis DNA 
amplified with an annealing temperature of 10°c. 
2.1 Plasmid and Host Cells 
2.1.1 Plasmid p36 
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CHAPTER 2 
MATERIALS 
Dr SA Shoemaker of the Eleanor Roosevelt Institute for Cancer 
Research prepared a partial DNA library of M.tuberculosis by 
cloning DNA, partially digested with the restriction enzyme MboI, 
into the BamHI site of the vector pBR322. One of the recombinant 
clones, p36, hybridised with a number of bands (about 6) 
generated by restriction enzyme digests (BamHI) of M.tuberculosis 
DNA, indicating that there may be multiple copies of the cloned 
DNA sequences present in the bacterial genome. This clone also 
hybridised with M.avium - intracellulare DNA (unpublished data). 
The repetitive nature of p36 made this recombinant clone a 
potential candidate for a diagnostic probe, and Dr LM Steyn 
(unpublished results) therefore, preceded to characterise p36 
further. A restriction enzyme map of p36 was prepared by cutting 
the plasmid with various restriction enzymes and by resolving the 
fragments according to size by agarose gel electrophoresis. p36 
was shown to contain an insert of mycobacterial DNA of 5.7 kb and 
the restriction map is shown in Fig. 2.1. 
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Fig. 2.1 Restriction Map of p36 
.... SY Y t 
( 0) BamHl; 
( 'v) p s tl; 
( ~) Ss tll. 
5: ' t 
( 0) EcoRl; ( T ) Mbol; ( .A) Kpnl; 
(+) Sall; (e) Smal; (0) Sstl; 
(-) Insert DNA;-(- - - ) villor DNA 
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Further subcloning of p36 and hybridisation with M.tuberculosis 
DNA digests identified the MboI/SstII fragment of approximately 
1.2 kb as the fragment responsible for the multiple banding 
pattern. 956 bp of this MboI/SstII fragment was sequenced and 
the sequence is shown in Fig. 2.2. 
The sequence reads from about 300 bp from the MboI site, through 
the KpnI, SmaI and the first SstII site. The fragment is 
extremely GC-rich (>80%) and contains many direct repeats. The 
high GC content and direct repeats made sequencing technically 
very difficult and this was particularly problematical around the 
KpnI site. There are no open reading frames of greater than 600 
nucleotides present in the sequence and it therefore, appears 
unlikely that this DNA fragment encodes a functional protein. 
Furthermore, subsequent experiments indicated that this fragment 
was not transcribed and the function of this element thus remains 
unknown. 
2.1.2 Plasmid p366 
Within this 956bp region was a 366bp fragment flanked by a KpnI 
and a Smar restriction enzyme site (Fig. 2.1 and Fig. 2.2). This 
fragment was shown to be responsible for the multiple banding 
pattern and was assessed as a possible DNA probe and cloned into 
pBR322 (p366, de Wit 1990). Subsequently, this fragment was 
assessed for use as the target sequence for amplification by PCR 
but was unsatisfactory due to failure of primer annealing near 
the KpnI site. A priming site 25 bp towards the SmaI site was 
subsequently selected and successful amplification of a 336 bp 
fragment (Fig. 2.2) was achieved (de Wit et al 1990) . 
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Fig. 2.2 Partial Sequence of the MboI/SstII Fragment 
of p36 
1 CGTTCTGGCC CTCCAGCAGC CCGCCGGCGC CACCGACGCC 
41 GACGCTGCCA GTCCCGGCTT TGCCAAATCG CGTTGCCG
CC 
81 GTTGCCGCCC TGGCCCGTCA GCCAGGCGTT GCCGCCG
TTA 
121 CCGCCGCTAC CACCCGTTTG CCTGCTATCG TGG
CACCGCC 
161 GTCGCCGCCG TTGCCGCCCT CGCCGACCAA CCC
GGCCTTG 
201 CCGCCCACGC CGCCGTTTCC GCCGTCGCNG TTGTC
GCTCT 
241 CCCCGCCGGC GCCGCCGGCG CCGCCGGAAC CGTAG
AACGT 
281 GCCGGCGTTA CCGCCGGCCC CGCCGCGACC ACCACT
TAGG 
321 TAC.CGGTGCC GCCGCTGCCG CCGGCGCCGC CAGAACCGA
C 
361 CAACCCGCCG ATACCGCCGT 'CGCCGCCGTC GCCGCCGAA
C 
401 CCGCCGAACC CGCCGGCTCC GCCGGCCCCA CCGGTGC
CGrr 
441 ATAGCAGGCC GGCATTACCG CCGTGACCAC CGTGGCCAGC 
481 GACAGTGGCG ACTCCGCCTG CACCGCCGGC CCCGCCCGAG 
521 CCGAAGACCG TGCCGCCGGC GCCGCCCGCG CCGCCGTCGC 
561 CGCCGGCAGC ACTGCCGAAG CCACCGTGCC CGCCGGCCCC 
601 GCCGACGCCA AACAGCCCGC CGCTGCCGCC GTCGCCGCCG 
641 GTCCCACCGG TGTCGCCGCA AGCCACCGAC GCCGCCCGAG 
681 CCGCCGCCC*G GGCCGAACAG CCCGCCGGCC CCGCCAGCCC 
721 CGCCGGTCCC ACCGGTGTCG CCGAAGCCGC CGGCGCCGCC 
761 GGCACCGCCG GCGCCGAACA GCCCACCGAC CCCGCCCGCA 
801 CCGCCGTTGC CACCGGCGGC CTGGGCGCCG CCGCCGAGGG 
841 CGGCGCCGCC TACGCCGCCG GCCCCGCCCG CGCCGAACAG 
881 CCCACCGGCG CCGCCGGCCC CGCCGGCACC CCCAGCGGCA 
921 TCGAAGAAAG GTGGTGAACC CGCCGTTGCC ACCGGA 
The 366bp fragment extends from a KpnI restriction site
(+) at 
base 323 to~ ~maI.res~riction site(*) at base 689. The target 
for DNA ampl1f1cat1on is a 336bp fragment extending fro
m base 349 
to bas7 684. The primer binding sites (25bp each) are 
underlined. 
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2.1.3 Host Cells 
p UC19 and JM109 cells were received from Prof. F Robb, Department 
of Microbiology, University of Cape Town, Rondebosch. 
2.2 Enzymes, Chemicals, Solutions and Media 
All reagents used were of high quality and suitable for use in 
molecular biology ~xperiments. All the reagents and suppliers 
are listed in Appendix A. 
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CHAPTER 3 
PREPARATION OF GENERAL MYCOBACTERIAL PROBE 
3.1 Introduction 
It has previously been demonstrated that non-specific binding of 
primers to M.tuberculosis DNA occurred at low annealing 
temperatures. It was felt therefore, that because of the similar 
GC content of the different Mycobacteria that one set of primers 
might be suitable for amplification of DNA from several 
Mycobacteria. The primers used are those that generate a 
specific 336 bp fragment from M.tuberculosis DNA at 10°c 
annealing temperatures. It was anticipated that PCR products of 
varying sizes would be generated by non-specific priming and that 
these products could be detected by visual examination of 
ethidium bromide stained agarose gels. PCR products are, 
however, often not visualised if there is little starting 
material (deWit, Maartens and Steyn 1990) such as in clinical 
.specimens and a suitable probe to detect the different molecular 
weight PCR products is therefore required. The preparation of a 
general probe will be described in this chapter and will be 
evaluated in Chapter 4. 
3.2 Preparation of Mycobacterial DNA 
A type culture strain of M.tuberculosis H37RV was obtained from 
the diagnostic Medical Microbiology laboratory at Groote Schuur 
Hospital, while strains of M.avium, M.fortuitum, M.gordonae, 
M.intracellulare, M.kansasii, M.marinum and M.scrofulaceum were 
obtained from the Tuberculosis Research Institute (Pretoria). 
M.bovis BCG (Tokyo strain) was obtained from the State Vaccine 
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Institute, (Pinelands, Cape Town) and was cultured on Sautons 
broth, while all the other mycobacterial strains were cultured on 
Lowenstein Jensen medium. The bacteria were harvested and the 
DNA was extracted as follows: the cells were suspended in 2ml of 
TES buffer (Tris-HCl, pH 8.5 (lOmM); EDTA, (lmM); NaCl (150m.M), 
and heated at 7o 0 c for 30 min. The cells were lysed by the 
addition of 10% SOS (1.5% final concentration) and an equal 
volume of buffered phenol. The lysates were mixed at 37°c for 3 
hours on an orbital shaker to ensure complete lysis and to 
enhance the extraction of proteins and lipids. The lysates were 
centrifuged (15 minutes in a Beckman microfuge) and the aqueous 
supernatants were extracted twice with an equal volume of 
chloroform: iso-amylalcohol (24:1 V/V). The DNA was precipitated 
by the addition of an equal volume of polyethylene glycol (PEG 
6000, Sigma) in 2.5M NaCl at room temperature. The DNA was 
harvested 15 minutes after the addition of the PEG by 
centrifugation for 15 minutes in a Beckman microfuge. The DNA 
pellet was washed twice with 70% ethanol and dried in a Speedivac 
concentrator (Servant) and finally dissolved in sterile, 
distilled water at a final concentration of 0.1-0.3 ug/ul. 
3.3 Preparation of p366 
Competent JM109 cells were prepared and transformed with p366 as 
described in Appendix B. This was followed by large scale 
plasmid extraction and purification by isopycnic gradient 
centrifugation (Appendix B). The results of these experiments 
will be discussed later in this chapter. 
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3.4 Amplification of a 336bp fragment by PCR 
The optimum buffer system and cycling parameters used for PCR has 
previously been determined (de Wit 1990). The final 
concentrations of components in the reaction vial were as 
follows:- 10% dimethyl sulphoxide, 50rnM KCl, lOrnM Tris, HCl pH 
8,3, 1,5 rnM Mg c1 2 and 0,001% gelatin, 200umols of each dNTP and 
1-2 umoles of each oligonucleotide primer and 2,5 units of Taq 
polymerase. 10 pg of p366 was then heated to 95°c for 10mins and 
added to the reaction vial. Because of the possibility of 
component exhaustion with a resultant plateau effect (see 
introduction) 4 identical reaction mixtures were prepared to 
ensure an adequate quantity of PCR product. 
Thirty temperature cycles (1 minute at 95°c and 2 minutes at 
10°c) were then performed in a custom made thermal cycling 
machine. After amplification the reaction mixtures were placed 
on ice and the DNA concentrated by precipitation with one tenth 
volume of 3M ammonium acetate and 2,5 volumes of absolute 
ethanol. The DNA pellet was washed with 70% ethanol, dried in a 
Speedivac concentrator (Servant) and resuspended in 15ul of 
sterile distilled wate~. 
3.5 Agarose Gel Electrophoresis 
3%, 4% or 5% gels were made by dissolving the. appropriate amount 
of agarose in TAE buffer (0,04M Tris-acetate, O,OOlM EDTA). This 
was done in a microwave oven. 20 ul of a stock solution of 
ethidium bromide (lOmg/ml) was added to 50ml of dissolved agarose 
and the gel poured approximately 3mm thick with the slot former 
already in position. Once the gel had set the slot former was 
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removed and the gel was placed in a tank of TAE buffer containing 
ethidium bromide {lOOul stock per 200ml TAE). The 15ul of each 
PCR reaction was loaded into the wells and a potential difference 
of 80 volts was usually applied for 11 ; 2 to 2 hours. After 
electrophoresis the fragments could be immed{ately visualised and 
the gel photographed. The desired 336bp fragment was cut from 
the gel. 
3.6 Electroelution 
A biotrap obtained from Schleicher and Schuell was used for all 
elutions of DNA from gels. The biotrap was placed in an 
electrophoresis tank containing Tris-borate buffer (0,045M Tris-
borate, O,OOlM EDTA). The gel slices containing the 336bp 
fragment were placed in the apparatus and a potential difference 
of 200 V was applied for 1 hour, after which the polarity was 
reversed for 20 seconds. The voltage was switched off, the DNA 
solution removed from the appropriate chamber and concentrated by 
precipitation with 1 tenth volume 3M ammonium acetate and 2,5 
volumes of absolute ethanol. The DNA pellet was washed twice 
with 70% ethanol, dried in a Speedivac (Servant) and 
reconstituted in sterile distilled water. 
3.7 Restriction Enzyme Digestion 
Digestion of the 336bp with BanI yields a 105bp fragment (which 
does not contain the primer sequences) as well as 2 other 
fragments (ie 146bp, 105bp and 85bp). Four micrograms of the 
336bp fragment was digested with BanI. The composition of the 
dig~stion mixture was as follows, 12ul, DNA; 6ul, BanI (10 
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units/ul); 4 ul, buffer (A Boehringer); and 18ul sterile, 
distilled water. The mixture was incubated at so 0 c for 21 / 2hrs. 
Thereafter DNA fragments were separated by electrophoresis in a 
4% agarose gel, for 2hrs at 80 volts. The 105bp fragment was 
identified, cut out, removed from the gel by electroelution and 
concentrated by precipitation with eth~nol. This fragment was 
later radiolabelled and used as a general mycobacterial probe 
(Chapter 4). 
3.8 Results 
The extraction procedure used for the preparation of 
mycobacterial DNA gave yields of 50-300ug of DNA per gram of wet 
cells. The absorbance ratio (260-280nm) was greater than 1.75 
indicating pure DNA preparations with minimal protein 
contamination. 
The transformation control yielded 1,3 x 108 colonies/ug of 
pUC19. Such yields are indicative of well prepared competent 
cells as well as good transformation methodology. 
Large scale plasmid extraction and purification by isopycnic 
gradient centrifugation yielded 48ug of p366 and the absorbance 
ratio (260-280nm} was 2.0. These results indicate good yields of 
high quality DNA (ie. minimal protein contamination). 
PCR using p366 as template, yielded the desired 336bp fragment 
(Fig. 3.1). Restriction enzyme digestion of the 336bp fragment 
resulted in the expected 3 fragments (146bp, 105bp and 85bp} 
which together with the gel purified 105bp fragment are 
demonstrated in Fig. 3.1. 
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Fig. 3.1 Amplification and Digestion of a 336bp Fragment 
4% agarose gel. Lane 1: Molecular weight marker. HaeIII digest 
of pBR322. Lane 2: Gel purified 336bp fragment. Lane 3: BanI 
digest of 336bp fragment. Lane 4: Gel purified 105bp fragment. 
Lane 5: Molecular weight marker. HaeIII digest of pBR322. 
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CHAPTER 4 
AMPLIFICATION OF MYCOBACTERIAL DNA BY PCR 
4.1 Introduction 
In this chapter, I will describe how mycobacterial DNA was 
amplified at 2 different annealing temperatures. The same 
oligonucleotide primers that generate a 336bp fragment from 
M.tuberculosis DNA were used for this amplification. The 
products generated were analysed by agarose gel electrophoresis. 
The DNA was transferred to a hybond-N-membrane and hybridised 
with the radiolabelled 105bp fragment prepared in Chapter 3. 
Because hybridisation was not with a homologous probe the affect 
of washes of different stringency was also assessed. 
4.2 Determination of annealing temperature 
The buffers and components used for PCR were the same as those 
described in Chapter 3. Mycobacterial DNA (30-40ng) was heated 
to 95°c for ten minutes and added to the PCR reaction vials. 
Thermal cycling (30 cycles) was then performed in a Techne PHC-2 
thermaL cycling machine. 
Two different temperature profiles were analysed, ie. 
i. 1 Minute 95°c, 1 minute 4o0 c and 1 minute 10°c. M.gordonae, 
M.kansasii, M.marinum, M.scrofulaceum and M.tuberculosis. 
DNA was used for assessment of this temperature profile. 
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ii. 1 Minute 95°c, 1 minute 5o 0 c and 1 minute at 10°c. 
M.tuberculosis, M.avium, M.gordonae, M.intracellulare, 
M.kansasii, M.marinum, M.scrofulaceum and Acinetobacter DNA 
was used for assessment of this temperature profile. 
After PCR, the DNA in the reaction mixtures was concentrated by 
precipitation with ethanol, washed with 70% ethanol, dried and 
dissolved in 30ul of ultrapure water. Fifteen microlitres of 
each reaction tube was subjected to electrophoresis in a 3% gel 
containing ethidium bromide. 
4.3 DNA transfer to Hybond-N-membrane 
DNA separated by agarose gel electrophoresis was transferred onto 
a Hybond-N membrane by a modified method of Southern (1975). The 
DNA was denatured by shaking the gel in an excess volume (500ml) 
of denaturing buffer (1,5M NaCl, 0,5M NaOH) for 45 minutes. The 
gel was then washed for 5 minutes in alkaline transfer buffer 
( 1,5M NaCl, 0,25M NaOH) and the DNA then transferred to Hybond-N 
membrane. The paper towelling was changed once and the transfer 
was allowed to proceed .overnight. The membrane was then 
airdried, wrapped in Saran wrap and UV-illuminated for 10 minutes 
to irreversibly bind the DNA to the membrane. 
4.4 Radiolabellinq DNA by Nick Translation 
Radiolabelling of DNA was performed in all cases with a Nick 
Translation Kit (Amersham No. N5000). Approximately 300 ng of 
the purified 105 bp fragment was used, to which was added lOul 
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nucleotide buffer solution, Sul dCTP (a-32 P} and sterile 
distilled water to make the volume up to 4Sul. Finally, Sul of 
enzyme solution containing DNA polymerase I was added. The 
mixture was incubated at 1s0 c for 2-3 hours. The reaction was 
terminated by the addition of Sul of xyelene cyanol dye. Forty 
five microlitres of Nick Translation buffer (lSOmM NaCl, SOmM 
Tris-Cl pH7,5, lOmM EDTA, 0,1% SOS} was added to give a final 
volume of lOOul. 
The probe was then purified by separation in a Sephadex G-50 spun 
column: A piece of siliconised glass wool was inserted into a 
1ml syringe. A small ruber ring was pushed down on top of the 
glass wool. The syringe was filled with Sephadex GSO 
(equilibrated in Nick Translation Buffer} and placed in a plastic 
tube and centrifuged at 1500g for 5 minutes. The sample (lOOul} 
was loaded and the syringe centrifuged for 5 minutes. The sample 
was collected in a microfuge tube. 
Before hybridisation the probe was denatured by heating it for 
10 minutes at 100°c. 
4.5 Hybridisation with General Mycobacterial Probe 
To reduce non-specific binding of the probe to the membrane the 
Hybond-N was placed in 40ml of pre-hybridisation solution (6 x 
SSC, 5 x Denhardts solution, 0,5% SOS} in a sealed plastic bag 
for at least 2 hrs at 42°c. 
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The fluid was then discarded and 20ml of hybridisation solution 
(6 x SSC, 5 x Oenhardts solution, 0,5% sos, 50% formamide) and 
the radiolabelled probe were added to the membrane. The bag was 
sealed and incubated with gentle shaking at 42°c overnight. 
After hybridisation the membrane was washed to remove non-
specific binding of the probe to the membrane. The following 
procedure was used. 
1. Two 45 minute washes with 500ml of washing solution I (2 x 
SSC, 0,05 Blotto, 0,1% SDS) at room temperature (Wash I) 
2. Autoradiography of membrane. 
3. Two 45 minute washes with 500ml of washing solution II (0.1 x 
SSC X 0.1% SOS) at 55°c (Wash II). 
4. Autor.adiography of membrane. 
5. Two 45 minute washes with 500ml of washing solution II at 
65°c (Wash III). 
6. Autoradiography of membranes. 
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4.6 Autoradiography 
An X-ray film (Curix RPI Agfa) was exposed to the membrane for a 
varying length of time (3hrs - 2 days) at -7o0 c. Under 
illumination of a red light only, the film was developed for 3 
minutes (Ilford Phenisol). It was then placed in a 2% acetic 
acid stop bath for 1 minute and finally in fixer (AMFIX) 
containing hardner for 3 minutes. The film was then washed under 
tap water for approximately 15 minutes and air dried. 
4.7 Results and Discussion 
The ethidium bromide stained gels of the material obtained after 
amplification with an annealing temperature of 4o0 c, are shown ·in 
Fi g. 4.la. Autoradiographs of the membrane after 3 washes of 
increasing stringency are demonstrated in Figures 4.lb, 4.lc and 
4.ld respectively. The gel indicates that a number of ill-
defined PCR products of varying molecular weights were generated 
from the mycobacterial DNA. There is also marked background 
smearing indicative of non-specific amplification. 
Hybridisation, followed by a low stringency wash (wash I), showed 
that binding of the general probe to PCR products was minimal for 
all the Mycobacteria except for·M.tuberculosis. Higher 
stringency washes resulted in complete removal of probe except 
for M.tuberculosis. 
Ethidium bromide stained gels of amplifications performed at an 
annealing temperature of 5o0 c are showin in Fig. 4.2a. 
Autoradiography of the membranes after washes of increasing 
69 
stringency are demonstrated in Fig. 4.2b, 4.2c and 4.2d 
respectively. The ethidium bromide stained gels indicate that 
distinct PCR products are generated only by M.kansasii, M.avium, 
M.intracellulare and M.tuberculosis DNA. A 336bp fragment as 
well as a smaller fragment are generated from M.tuberculosis DNA. 
The PCR products of M.intracellulare and M.avium (very faint 
band) have a similar electrophoretic mobility to the 336bp 
product of M.tuberculosis. The PCR product of M.kansasii has a 
size of 420bp. This cannot be estimated from Fig. 4.1 as no 
markers were used but can be deduced from Fig. 5.1 (see later). 
The marked background smearing noted with the 40°c annealing 
temperature is not as obvious in the gel and indicates that 
amplification is more specific at so0 c annealing temperature. 
Hybridisation followed by low stringency washing (wash I) shows 
good binding to the PCR products generated from M.tuberculosis 
DNA and moderate binding to PCR products from the other 
Mycobacteria. After wash II there is still binding to M.avium 
DNA bu~ after high stringency (washing III) ther~ is complete 
removal of probe except for M.tuberculosis. 
Although PCR products are generated by these primers the general 
probe does not bind satisfactorily to these products. Previous 
experience (de Wit et al 1990) indicates that M.tuberculosis DNA, 
prepared from clinical specimens, and subjected to PCR cannot be 
detected by ethidium bromide stained gels in most cases but can 
be detected following hybridisation with a specific probe. As 
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the products generated from non-tuberculous DNA can be visualised 
by ethidium bromide stained gels but show unsatisfactory 
hybridisation, it is unlikely that products which cannot be 
visualised (ie. DNA from clinical specimens) will be detected by 
this general probe. 
Because of these problems it was decided to abandon this approach 
and select a few of the clinically important non-tuberculous 
Mycobacteria and prepare specific probes for the products 
generated by PCR. 
A comparison of the products generated when annealing 
temperatures of 4o 0 c and so0 c needs to be considered. As would 
be expected fewer bands are seen in the latter case but well 
defined products are generated from 3 clinically important non-
tuberculous Mycobacteria (M.avium, M.intracellulare and 
M.kansasii). Furthermore, the marked background smearing seen at 
a 40° annealing temperature is not evident at a so0 annealing 
temperature. Therefore, for further amplifications annealing 
temperatures of so 0 c were used. The use of higher annealing 
temperatures also has other advantages when amplification from 
c l inical specimens is being considered, eg. 
higher annealing temperature result in less non-specific 
binding of primer. This is an important consideration when 
there are many templates present, such as in DNA prepared 
from clinical specimens, 
with greater specificity there is more selective 
amplification and higher yields of the desired fragment (ie. 
increased sensitivity). 
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Fig. 4.la: Ethidium bromide 
stained gel of material 
obtained after amplification 
of mycobacterial DNA using an 
annealing temperature of 
40°c. Lane I: M.gordonae. 
Lane 2: M.kansasii. 
Lane 3: M.marinum, 
Lane 4: M.scrofulaceum, 
Lane 5: M.tuberculosis 
Fig. 4.lb: Autoradiograph of 
membrane after hybridisation 
with the general probe and low 
stringency ·washing (Wash I) 
Lanes 1-5 as in 4.la. 
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Fig. 4.lc: Autoradiograph of 
membrane after hybridisation 
with the general probe and 
washing with wash II. 
Lanes 1-5 as in 4.la. 
Fig. 4.ld: Autoradiograph of 
membrane after hybridisation 
with the general probe and 
high stringency wash 
(wash III). Lanes 1-5 as 
in 4.la . 
Fig. 4.2a: Ethidium bromide stained gels of material obtained 
after amplification of mycobacterial DNA using an annealing 
temperature of so 0 c. Lane 1: M.gordonae. Lane 2: M.kansasii. 
Lane 3: M.marinum. Lane 4: M.scrofulaceum, Lane 5: 
M.intracellulare. Lane 6: M.avium. Lane 7: M.tuberculosis (336bp 
fragment arrowed). Lane 8: Acinetobacter (Note: 2 separate gels). 
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Fig. 4.2b: Autoradiographs of membranes after hybridisation with 
the general probe and low stringency washing (wash I) Lanes 1-8 
as in 4.2a. 
1 2 3 4 5 6 7 8 
Fig. 4.2c: Autoradiographs of membranes after hybridisation with 
the general probe and washing with wash II. Lanes 1-8 as in 
4.2a. 
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Fig. 4.2d: Autoradiographs of membranes after hybridisation with 
the general probe and high stringency washing (wash III). 
Lanes 1-8 as in 4.2a. 
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CHAPTER 5 
PREPARATION AND HYBRIDISATION WITH SPECIES SPECIFIC PROBE 
5.1 Introduction 
The problems with the general probe have been discussed in 4.7. 
This chapter deals with the preparation of specific probes 
directed against the amplification products of M.avium, 
M.intracellulare and M.kansasii. The specificity of these probes 
will be assessed as well as the lower limits of detection 
(sensitivity) of the PCR assay. 
5.2 Amplification of Mycobacterial DNA 
Thirty to forty micrograms of DNA from M.tuberculosis, M.avium, 
M.gordonae, M.intracellulare, M.kansasii, M.marinum, 
M.scrofulaceum and Acinetobacter was subjected to PCR using the 
following thermal cycling profile: 1 minute, 95°c; 1 minute, 
so0 c and 1 minute, 10°c. Buffers and components were the same as 
described previously. After -,amplification the DNA was 
concentrated by ethanol precipitation and the PCR products 
separated and visualised by ethidium bromide stained agarose 
gels. The DNA was transferred to hybond-N-membranes as 
previously described. 
5.3 Preparation of Probes 
M.avium, M.intracellulare and M.kansasii DNA {30-40ng) were 
amplified using an annealing temperature of so 0 c as described 
previously. The DNA in the reaction mixture was then 
concentrated, washed, dried and reconstituted in 15ul of 
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ultrapure water and subjected to electrophoresis in a 3% gel. A 
300bp fragment of M.avium and M.intracellulare as well as a 420
bp 
fragment of M.kansasii were cut from the gel. A smaller, (180bp) 
fragment of M.intracellulare (Band II) was also cut from the gel. 
These bands are shown in Fig. 5.1 and the molecular weights
 were 
calculated from the relative electrophoretic mobilities of
 the 
marker DNA. All DNA was electroeluted, concentrated and 
reconstituted in 30ul of ultrapure water as previously des
cribed. 
Ten microlitres of each of these DNA solutions was then s
ubjected 
to further amplification (30 cycles) using more stringent 
annealing conditions (1 minute 95°c and 2 minutes at 10°c). The 
DNA was again concentrated, washed, dried and reconstitute
d in 
15ml ultrapure water and subjected to electrophoresis in a 3% 
agarose gel. The desired bands were visualised and the am
ount of 
DNA estimated by the intensity of straining. The DNA was 
cut 
out, electroeluted and the DNA finally concentrated, washe
d, 
dried and reconstituted in ultrapure water (20ul). 500 ng of 
each fragment was then labelled by the Nick Translation pr
ocedure 
as previously described. 
5.4 Hybridisation with Specific Probes 
The membrane prepared in 5.1 was sequentially hybridised w
ith 
M.intracellulare, M.kansasii and M.tuberculosis probes. The 
procedure used for this sequential hybridisation is shown 
in 
Table 5.1. 
Table 5.1: 
step No. 
1. 
2 • 
3. 
4. 
5. 
6. 
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Procedure 
Hybridisation with M.kansasii probe. 
Washes with solution I (room temperature) and Solution 
II (55°c). Solutions I and II as described in 4.5. 
Autoradiography 
Washes with solution II at 65°c. 
Autoradiography 
Removal of probe. Membrane boiled in 0,1% sos for 
2 hours. 
7. Hybridisation with M.intracellulare probe. 
8. Repeat steps 2 to 6. 
9. Hybridisation with M.intracellulare band II probe. 
10. Washes with solution I (room temperature) and 
solution II at 65cc. 
11. Repeat steps 5 to 6. 
12. Hybridisation with M.tuberculosis probe. 
13. Repeat step 10. 
14. Autoradiography 
s.s Assessment of sensitivity 
Serial 10-fold dilutions of chromosomal M.intracellulare DNA were 
made; lOOpg, lOpg, lpg, lOOfg, and lOfg of DNA were added to 
separate reaction vials and amplification performed as previously 
described. The products were analysed by ethidium bromide 
stained agarose gel and thereafter the DNA transferred to Hybond-
N-membrane and hybridised with the M.intracellulare probe. 
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5.6 Results and Discussion 
The amplified products are shown in Fig. 5.1. A 300bp product is 
generated from both M.avium and M.intracellulare DNA. A smaller 
180bp fragment is also generated from M.intracellulare DNA. A 
420bp fragement is produced from M.kansasii DNA. Other smaller 
fragments are seen in these mycobacteria but these have not been 
studied further. 
Autoradiographs following hybridisation with the M.kansasii probe 
and washes of increasing stringency are shown in Figs. 5.2a and 
5.2b. The M.kansasii probe cross hybridises with most of the 
Mycobacteria if washes at ss 0 c are employed but is entirely 
specific for M.kansasii following high stringency washes (65°c). 
Autor~diographs following hybridisation with the M.intracellulare 
probe and washes of increasing stringency are shown in Fig. 5,3a 
. and 5,3b. The M.intracellulare probe cross hybridises with most 
of the Mycobacteria if washes at 55oC are employed but is 
specific for M.intracellulare but also M.avium when high 
stringency washes (65°c) are used. 
The low molecular weight band of M.intracellulare (Band II) was 
used as a probe in an attempt to differentiate M.avium and 
M.intracellulare. An autoradiograph following hybridisation with 
this probe and high stringency washes are shown in Fig. 5.4. The 
probe hybridises with the M.intracellulare product but also with 
... 
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products from a number of other Mycobacteria. 
An autoradiograph following hybridisation with the M.tuberculosis 
probe (ie the 105bp general probe) and high stringency washes is 
shown in Fig. 5.5 The probe is entirely specific for 
M.tuberculosis. This observation confirms the findings 
demonstrated in Fig. 4.2d. 
I n the sensitivity study no products could be visualised by 
ethidium bromide staining of the gel when a starting DNA 
concentration of lOOpg or less was used. An autoradiograph 
following hybridisation with the M.intracellulare probe is shown 
i n Fig. 5.6. The signal is very strong when 100 pg of DNA is 
used and can still be detected when lOfg of DNA is used. There 
i s no signal with the negative control. The signal from lOOfg is 
f ainter than from lOfg. This discordant result cannot be 
adequately explained. 
Because of different sizes of the products generated by PCR the 
M.intracellulare and M.kansasii probe can be used to detect . 
M.avium, M.intracellulare and M.kansasii DNA without any cross 
hybridisation from other Mycobacteria and other bacteria (eg. 
Acinetobacter). This finding together with the extreme 
sensitivity of the assay (lOfg of DNA) makes this approach 
suitable for the detection of mycobacterial DNA in clinical 
samples. The M.intracellulare probe however, cannot be used to 
differentiate M.avium from M.intracellulare. This is not 
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surprising as the similarity of these two organisms is well 
established. Hybridisation with another M.intracellulare probe 
(Band II) was also not suitable for making this distinction as 
hybridisation with other Mycobacteria also occurred. The 
M.avium and M.intracellulare fragments will be sequenced and 
differences in these two fragments are anticipated. Hopefully 
these differences will include restriction enzyme sites which 
could then be used to make a distinction between these two 
organisms. 
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Fig. 5.1: Ethidium bromide stained gel of material obtained after 
amplification of mycobacterial DNA using an annealing temperature 
of so 0 c. Lane I: M.tuberculosis arrow indicates 336bp fragment. 
Lane 2: Marker. HaeIII digest of pBR322. Lane 3: M.avium arrow 
indicates 300bp product. Lane 4: M.gordonae. Lane 5: 
M.intracellulare, arrow indicates 300 bp and 180bp 
(faint)product. Lane 6: M.kansasii, arrow indicates 420bp 
product. Lane 7: M.marinum. Lane 8: M.scrofulaceum. 
Lane 9: Acinetobacter. Lane 10: Marker. HaeIII digest of pBR322. 
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Fig. 5.2a: Autoradiograph of membrane following hybridisation 
with the M.kansasii probe and washing at 55°c. 
Lanes 1-10 as in 5.1 
1 2 3 4 5 6 7 8 9 10 
Fig. 5.2b: Autoradiograph of membrane following hybridisation 
with the M.kansasii probe and washing at 65°c. 
Lanes 1-10 as in 5.1 
1 2 3 4 5 6 7 8 9 10 
Fig. 5.3a: Autoradiograph of membrane following hybridisation 
with the M.intracellulare probe and washing at 55°c. 
Lanes 1-10 as in Fig. 5.1 
1 2 3 4 5 6 7 8 9 10 
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Fig. 5.3b: Autoradiograph of membrane following hybridisation 
with the M.intracellulare probe and washing at 65°c . 
Lanes 1-10 as in Fig. 5.1 
1 2 3 4 5 6 7 8 9 10 I 
Fig. 5.4: Autoradiograph of membrane following hybridisation 
with M.intracellulare band II probe and washing at 65°c. 
Lanes 1-10 as in Fig. 5.1 
1 2. 3 4 5 6 7 8 9 10 
Fig. s.s: Autoradiograph of membrane following hybridisation 
with the M.tuberculosis probe and washing at 65°c. 
Lanes 1-10 as in Fig. 5.1 
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Fig. 5.6: Assessment of Sensitivity 
1 2 3 , ·4 · s 6 7 
Autoradiograph of membrane after amplification of 
M.intracellulare DNA followed by hybridisation with the 
M.intracellulare probe. Amount of M.intracellulare DNA used in 
PCR reaction: Lane 1, lOOpg. Lane 2, lOpg. Lane 3, lpg. 
Lane 4, lOOfg, Lane 5, lOfg, Lane 6, negative control. 
Lane 7, lng (positive control). 
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CHAPTER 6 
DISCUSSION · 
The increasing prevalence of non-tuberculous infections together 
with the problems associated with conventional detection 
techniques stress the importance of establishing a new, rapid, 
specific and sensitive assay for the detection of non-tuberculous 
Mycobacteria. In this study, I have shown that with the use of 
one pair of primers and two DNA probes, three clinically 
important non-tuberculous Mycobacteria ie. M.avium, 
M.intracellulare and M.kansasii can be detected in as little as 
lOfg of starting DNA. This represents the amount of DNA present 
in less than 10 organisms, and therefore, makes this assay 
suitable for the detection of these Mycobacteria in clinical 
specimens. 
Since M.tuberculosis still h~s a high prevalence in many third 
world countries and also causes considerable morbidity in first 
world countries, the detection of this organism should be 
included in any PCR detection scheme. The M.tuberculosis probe 
was shown to be entirely specific for M.tuberculosis when 
annealing temperatures of so 0 c are used. However, the product 
generated is of a size similar to that of M.avium and 
M.intracellulare and it would therefore be impossible to 
distinguish these organisms should all three probes be used 
together. The following id~ntification scheme is therefore 
suggested:-
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1. DNA prepared from clinical specimens is subjected to two PCR 
reactions using the same primers, one reaction has an 
annealing temperature of 10°c and another an annealing 
temperature of so 0 c. At 10°c primer annealing is specific 
for M.tuberculosis. A smaller band is also generated from 
M.bovis BCG DNA. At so0 c PCR products will be generated from 
both M.tuberculosis and non-tuberculosis Mycobacteria. 
2. After the DNA has been transferred to membranes they are 
hybridised with the following 3 probes; M.avium-
intracellulare, M.kansasii and M.tuberculosis. The 
hybridisation is followed by high stringency washes. 
3. When an annealing temperature of 10°c is used, M.tuberculosis 
and M.bovis BCG will be identified and distinguished by a 
signal obtained from hybridisation to a 336bp and 256bp 
product respectively. 
4. When an annealing temperature of so 0 c is used M.avium -
M.intracellulare and M.kansasii will be identified by a 
signal obtained from hybridisation to a 300bp and 420bp 
product respectively. The absence of hybridisation at an 
annealing temperature of 10°c indicates that non-tuberculous 
Mycobacteria are responsible for the signal. 
Such an approach would require only 3 days. This scheme has not 
yet been applied to clinical specimens. However, the optimum 
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extraction and purification of mycobacterial DNA from clinical 
specimens has already been established {de Wit et al 1990) and 
problems in this area are therefore not anticipated. The problem 
of contamination, however, does arise when extraction and 
amplification of mycobacterial DNA from clinical specimens is 
. 
attempted. Because of the sensitivity of the PCR reaction 
amplification of contaminating DNA is a major problem and various 
authors have suggested ways of avoiding these false positives 
{Porter-Jordan and Garret 1990, Lo et al 1988, Kitchin et al 
1990, Kwok et al 1989). Another factor which also needs to be 
considered is the widespread environmental presence and the well 
known colonisation characteristics of the non-tuberculous 
Mycobacteria. A positive PCR result may therefore indicate 
contamination, colonisation, latent infection due to previous 
exposure or true infection, and results will therefore have to be 
evaluated very carefully. 
It is noted that the 3 probes also reflect well established 
phylogenetic relationships between the Mycobacteria used in this 
study. Members of the M.tuberculosis complex (M.tuberculosis and 
M.bovis BCG) are both recognised by one probe. M.avium and 
M.intracellulare are recognised by a separate probe while 
M.kansasii shows no cross hybridisation with other Mycobacteria. 
This assay meets the desired criteria as a diagnostic test ie. 
rapidity, sensitivity and specificity and it is hoped that 
clinical trials will be conducted in the near future. 
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APPENDIX A 
ENZYMES, KITS, SOLUTIONS AND MEDIA 
A.1 Enzymes and Kits 
BanI 
KpnI 
SmaI 
Boehringer 
Boehringer 
Boehringer 
Taq Polymerase New Eng Biolabs & Cetus Corp. 
Nick Translation Kit (No. 5000) Amersham 
A.2 Chemicals, Reagents and Other Materials 
Agarose (SeaKem GTG} 
Ammonium Acetate 
Ampicillin 
Blotto (milk powder) 
Boric Acid 
Bromophenol blue 
Calcium chloride 
Caesium chloride 
Chloroform 
Chromatography paper 3mm 
Deoxynucleotide triphosphates 
Dimethyl sulphoxide 
Ethylenediaminetetraacetic 
acid (EDTA} 
Ethidium bromide 
Ethanol 
Fixer (AMFIX) 
Formamide 
Gelatin 
Glucose 
FMC Bioproducts 
Merck 
Beechams 
Carnation 
Merck 
Sigma 
Merck 
Boehringer 
BDH 
Whatman 
Boehringer 
Merck 
Boehringer 
Merck 
Merck 
Maybaker 
BDH 
Difeo 
BDH 
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Glycerol Merck 
Hardener {'S' Type) Maybaker 
Hybond N Amersham 
Hydrocloric acid Merck 
8-Hydroxyquinolone Merck 
Isoamyl alcohol Merck 
Lysozyme Boehringer 
Lithium Chloride Sigma 
Magnesium sulphate Merck 
Magnesium chloride BDH 
Manganous chloride BDH 
Methanol Merck 
2-Mercapto ethanol Merck 
3-(N-Morpholino]propanesulfonic Sigma 
acid (MOPS) 
Phenol BDH 
Polyethylene glycol Sigma 
Potassium acetate Fluka 
Potassium chloride Merck 
Sephadex G50 Pharmacia 
Sodium chloride Merck 
Sodium citrate 
Sodium dodecyl sulphate 
Sodium deoxycholate 
Sodium hydroxide 
Sterile distilled water 
Sucrose 
{SDS) 
BDH 
Sigma 
Hopkin & Williams CTD 
BDH 
BDH 
BDH 
Tris (hydroxymethyl) amino BDH 
methan {Tris) 
Triton 
X-ray film (curix RPI) 
BDH 
Agfa 
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X-ray film developer (Ilford Phenisol) 
A.3 Media and Solutions 
Denhardts solution. 100 x - 2% w/v Bovine Serum Albumin 
2% w/v Ficoll 
Luria agar: 
Luria broth: 
lOg trytone 
5g yeast 
10g NaCl 
2% w/v Polyvinyl pyrollidine 
12g Difeo agar 
pH 7,2 
Total volume 1 litre 
10 g tryptone 
5 g yeast 
10 g NaCl 
pH 7,4 
Total volume 1 litre 
Both agar and broth were sterilised at 11s
0 c for 15 minutes and 
stored at room temperature. 
Lowenstein Jensen slopes were prepared by the media division of 
the Department of Medical Microbiology, University of Cape Town. 
Phenol: Phenol was melted at 57°c. 8-Hydroxyquinolone was added 
to a final concentration of 0,1%. Repeated extractions with an 
equal volume of lmM Tris pH 8 were performed until the pH of the 
aqueous phase exceeded 7,6. 2-Mercaptoethanol was added to a 
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final concentration of 0,2% and the phenol was stored under O,lM 
Tris pH 8 at 4°c. · 
Ampicillin (25 mg/ml) was stored at -20°c in aliquots and used at 
a final concentration of 25ug/ml 
A.4 suppliers 
Sigma: 
Merck: 
BDH: 
PO Box 14508, St Louis M063178, USA 
Frankfurter Strasse 250, D-6100, 
Darmstadt, Germany 
Poole, England 
Bio-Rad Labs: 32nd and Griffin Ave, Richmond, 
California, 39804. 
FMC Corp: 5 Maple Str, Rocklands, Maine, USA 
Schleicher & Schnell: D-3354 Dassel, West Germany 
Spectrum Medical Industries: 60916 Terminal Annex, 
Los Angeles 90054. 
Hopkin & William Ltd.: ~hadwell Heath, Essex, England 
Boehringer Mannheim GmbH: Biochemica, Po Box 310, 
120, D-6800, Mannheim 31, 
West Germany 
Pharmacia Fine Chemicals: Uppsala Sweden 
Amersham: Little Chalfont. Buckinghamshire. England. 
BRL: Cowley Mill Trading Estate. Longbridge Way, 
Uxbridge, Middlesex, England~ 
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APPENDIX B 
COMMONLY USED TECHNIQUES IN MOLECULAR BIOLOGY 
B.1 Preparation of Competent Cells 
A single JM109 colony, grown on minimal medium, was inoculated 
into lOmls of modified Luria broth (Luria broth with MgS04 lOmM, 
MgCl lOmM and glucose 20 mM). The cells were incubated for 
approximately 18 hrs at 37°c with aeration ((1,8 - 2 x 10 3 rpm. 
Labline. Orbit Environment Shaker). The cells were cooled on ice 
for 30 minutes and thereafter 2mls of the culture were mixed 
with lOOmls of prewarmed modified Luria broth and the optical 
density at 600nm measured. The optical density of the mixture 
was adjusted to between 0,02 - 0,03. 50mls of this mixture was 
placed in a 500 ml conical flask and incubated at 37°c for 1 to 2 
hours with shaking (2,5 - 3,0 x 103 rpm) after which the optical 
density was again measured. The optical density at 600nm was 
allowed to reach 0,5. 
The culture was then placed on ice for 10 to 15 minutes and then 
dispensed into sterilised corex tubes and centrifuged at 2000 rpm 
for 12 minutes at 4°c in a YA20 rotor (Beckman Centrifuge). 
After centrifugation the combined pellets were resuspended in 
33mls of resuspension solution 1 (lOOmM KCL, 50mM Mnc1 2 , 30mM 
potassium acetate (ph, 7,5), lOmM cac12 and 15% glycerol). 
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The cell suspension was centrifuged as above and then resuspended 
in 8mls of resuspension solution 2 {lOmM M.O.P.S, lOmM KCL, 75mM 
cac12 , 15% glycerol and pH adjusted to 6,8). 
The cells were then incubated on ice for fifteen minutes and 
200ul aliquots were dispensed into plastic vials and snap frozen 
with alcohol and dry ice. The cells were stored at -7o
0 c. 
B.2 Transformation of JM109 cells with p366 
Competent JM109 cells stored at -7o 0 c were thawed slowly (30 
minutes) on ice before transformation. One microlitre of a p366 
solution {20ng/ul) was added to 200 ul of competent cells and 
placed on ice for at least 40 minutes. As a transformation 
control circular pUC19 {lOug) was added to the competent cells. 
The cells were then heat shocked at 42°c for 2 minutes after 
which they were incubated with 1ml of prewarmed Luria broth at 
37°c for 1 hr for expression of the B lactamase gene encoding 
ampicillin resistance. Aliquots (50 . ul or 100 ul) of the 
suspensions were then spread onto Luria agar plates containing 
ampicillin. After the liquid had been absorbed, the plates were 
inverted and incubated at 37°c overnight. 
Competence of the JM109 cells was assessed from the pUC19 
transformation and thereafter the plates with colonies from the 
p366 transformation were wrapped in Saran wrap and stored at 4°c. 
96 
B.3 Large scale Plasmid Extraction 
The method used for preparing large quantities of plasmid DNA was 
a modification of that described by Greenaway and Dale (1983). 
A single bacterial colony was picked from a Luria-agar plate 
containing ampicillin and inoculated into 10ml of Luria broth 
containing ampicillin. This was incubated at 37°c with shaking 
for approximately 4 hours. 
All 10ml of the culture was inoculated into 200ml of pre-warmed 
Luria broth (containing ampicillin). To maximize surface 
aeration the broth was divided into four 500ml flasks (ie. 50 ml 
in each) and left shaking at 37°c for 15 hours. 
The cells were harvested by centrifugation at 6000rpm for 15 
minutes at 4°c in a JA-10 rotor. All culture supernatant was 
removed. 
The cells were resuspended in 6ml of 25% sucrose in 0.05M Tris 
HCl pH8.0 and transferred to a polypropylen~ centrifuge tube. 
The cells were maintained on ice. 
A spatula tip of powdered lysozyme was added to the cell 
suspension which was subsequently swirled on ice for 5-10 
minutes. 6ml of 0.25M Na 2 EDTA pH8 was added followed by 
swirling on ice for 5 minutes. 
97 
10ml of Triton/DOC solution {1% Triton, 0.4% Sodium deoxycholate 
in O.OlM Tris, O.OOlM Na2 EDTA, pHS) was rapidly added from a 
10ml pipette. Even mixing was ensured by drawing up and 
expelling three times. The mixture was left on ice for 20 to 30 
minutes. 
Cell debris and chromosomal DNA was pelleted by centrifugation at 
10 ooorpm for 2 hours at 4°c in a JA20 rotor. Because the 
bacterial chromosome is attached to the cell membrane it will be 
pelleted together with the membrane in a detergent solution. 
The cleared lysate (supernatant) was decanted into a plastic 
container, the volume made up to 10 ml with Triton/DOC solution 
and kept chilled prior to isopycnic gradient centrifugation. 
Plasmid Purification by Isopycnic Gradient Centrifugation 
Isopycnic gradient centrifugation is the separation of 
macromolecules according to their densities. For DNA separation 
a caesium chloride {CsCl) solution of l.6g/ml density is made. 
9.5g of CsCl was dissolved in the 10ml of DNA solution (0.95g/ml 
CsCl) and 0.2ml of ethidium bromide {lOmg/ml) was added. The 
solution was transferred to polyallomer tubes which were heat 
sealed and centrifuged in a VTi65 rotor at 50 OOOrpm for 15 hours 
at 20°c. 
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The DNA attained an equilibrium position in the tube at a level 
corresponding to its density and was visualized under an 
ultraviolet light of 375nm wavelength. Usually two bands were 
visible, the higher band corresponding to chromosomal and nicked 
plasmid DNA, and the lower band corresponding to covalently 
closed supercoiled plasmid DNA. The difference in density is due 
to the different amounts of ethidium bromide intercalation 
between supercoiled DNA (plasmid) and chromosomal DNA. 
The plasmid was eluted through the side of the tube by puncturing 
both the top and the side of the tube. This procedure avoided 
the RNA contamination which occurs if elution takes place through 
the bottom of the tube. 
Removal of Ethidium Bromide and Excess cscl 
Ethidium Bromide was removed ?Y adding an equal volume of isoamyl 
alcohol, vortexing the tube and separating the two phases by a 
two-minute centrifugation step. The upper organic layer was 
discarded and the procedure was repeated until there was no pink 
colour visible in either phase. 
The plasmid preparation was then dialysed in TE buffer (O.lM 
Tris, O.OlM EDTA pH8). The buffer was changed twice at four 
hourly intervals and then left at 4°c overnight. After removing 
the DNA solution from the dialysis bags, 400ul aliquots were 
dispensed into eppendorf tubes and 1 tenth volume 4M LiCl and 2,5 
volumes absolute ethanol were added. The DNA was stored in this 
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precipitated form at -20°c. 
For further use aliquots were removed from -20°, centrifuged for 
15 minutes in a microfuge, washed twice with 70% ethanol, dried 
and resuspended in sterile distilled water. To determine the 
plasmid yield and purity, an aliquot was scanned from 220nm to 
300nm on a Beckman DU-40 spectrophotometer. 
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